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Abstract 
Helicobacrer pylori i a tlage l lated cork cre" . s low growing neutroph i l ic gram negati e 
ureol t ic  organ i  m .  It ha an extraord inary ab i l ity to e tab l i  h i nfection in human stomach 
that can la t for year or decade . It eradication remains an important pub l i c  health 
cha l lenge e pec ia l l )  in l ight of broaden ing i nd ications and i ncrea ing ant im icrobial  
re i tance. 
AIM: i) Ident i fication of H PJ'lori in AE pat ient i i )  Determ ination of the prevalence of 
ant ib iotic resi tance gene (mutation in 23S rRNA gene in c lar ithromycin,  and de let ion in 
RdvJ. gene in metron idazole) among H. pylori stra ins  isolated from U.A . E  pat ients by 
1 I  i ng molecu lar method, i i i )  Ascerta i n  whether Cag A- posi t ive H pylori stra ins 
corre late w i th the ant ib iot ic re istance stra i ns or not and iv )  Screen ing for new H. pylori 
stra i ns i n  UAE through the ph logenetic analysis of the 23S rRNA m idd le region of the 
gene. 
METHODS: The ident i fication of H. pylori i n  UAE pat ients was carried on by primary 
screen ing for H pylori us ing CLO test wh i l e  the confi rmat ion test were done us ing PCR 
techn ique .  The preva lence of ant ib iot ic  res istance genes (mutation i n  23S rRNA gene i n  
c larithromyc in ,  and  deletion i n  RdYA gene in metron idazole) among H. pylori stra ins 
i o lated from U.A.E pat ients and Cag A gene re lat ion between th is  gene and ant ibiot ic  
res istant genes were stud ied by PCR and sequenc ing techn ique. Phylogenet ic analysis of 
the 23S rRJ.lA gene was analyzed by us ing the software C l usta lX,  vers ion 2. Reference 
sequences used i n  the a l i gnment was obtai ned from N C B I  data base for a l l  23s rRNA 
from d i fferent H pylori stra ins. 
v 
RESULTS: 26 out of 90 bi p )  ample were pos i tive for H. pylori u ing PCR \\ hereas 
onl) 22 \\ ere po i t i  e w hen te ted b LO te t. Re i tance to c larithrom c i n  and 
metron idazol w a  detected in 9 and 3 of tra in , re pectivel . Of the c larithrom)c in 
re i tant tra i n , 2 tra in  had the 2 1 42G mutati n i n  the 23S rRNA gene, 5 tra i n  in  
2 1 43 , I  tra i n  111 2 1 43 and 1 tra in  of highly changed i n  equence. Of the 
metron idazole re i tant tra in , de letion in rdxA gene was detected 111 3 stra ins which 
were negati e for C LO te t .  0 A sequence phylogenet ic analysi of the 23S rRNA 
m iddle region of the gene ind icate that the stra ins from UAE harbor a un ique 23S rRNA 
equence that i common among i so late from the UAE patient and d i fferent than other 
tra i n  publ i shed in the C B l  database. 
CONCLUSION: This study i the first t ime d ne i n  the UAE where a ign i ficant proportion 
of gastric  mucosal biopsies obta ined in the UAE are posit i  e for Genes assoc iated with 
C larithromyc in  and Metron idazole res i stance (ma in ly  i n  C l arithromyc in ) .  A2 1 43G 
remains  the most pre alent point m utation i nvolved, thus suggest ing that new therapeutic 
strategies are needed. 
Key Words: H. pylori; Antib iotic res istant genes; Cog A; Phylogenet ic Analysis of 23S 
rRNA .  
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1.1 .  Overview 
I n  the early 1 9  0 , Dr . Barr Mar ha l l  and Robin Warren from Austra l i a  
d i  co  ered bacteria i n  the tomach l i n ing  of pat ient wi th chron ic ga tr i t is and 
peptic u lcer (Marsha l l  and Warren, 1984). It wa orig ina l ly named Campylobacter 
pyloridi , becau e i t  \\ as tructura l l  i m i  lar t o  other ampy/obacter spec ies, uch as 
C. je jllni (gut pathog n \\ hich has the abi l i ty to colon ize the gastr ic mucosa of 
an imal ) ( Hole ton, 2004) .  Campylobacter pyloridi as renamed Campy/obacter 
pylori to fit w i th the name of other enteric pathogens. I n  1989, it was fi na l ly named 
Helicobacler pylori ba ed on funct ional and enzymatic propert ies ( Holeston, 2004). 
This bacteri um wa flagel lated corkscrew, slow growing neutrophi l ic gram negat ive 
ureolytic organ ism ( achs et aI. , 2002 ; Roussos el aI. , 2003 ) .  It has an extraord i nary 
abi l i ty to establ i h i n fect ion i n  human stomach that can last for years or decades 
( Kersu lyte el aI. , 2000) .  I n  order to JenQ\ more about H. p ylori, DNA mot i fs at 
se eral i n formative loc i in more than 500 stra i ns  of thi s  bacteria from five 
cont i nent were stud ied by peR and sequenc i ng, and thus to ga i n  i ns ights i nto the 
e o lut ion of th is  gastric pathogen .  F ive types of DNA mot i fs such as deletion, 
i nsert ion, and subst i tut ion were found at the r ight end of H. pylori cag Pathogenic i ty 
I s land. As  a resu l t  of a study, three mot i fs types were found to be common; type I ,  
types I I  and type 1 I 1  (kersu lyte e t  a/ ., 2000) .  
Walker and Edwards (2003)  reported that H. pylori are most ly transm itted by 
ora l -ora l and faecal-oral routes. Many important risk factors are present and can 
cause i n fect ion by this  bacteria; such factor are :  low soc ia l  c lass, overcrowd ing and 
home env i ronment dur ing chi ldhood (e. g .  bed-shari ng) .  The preva lence of H. pylori 
i n  developed countries was compared wi th deve loping countries, and the resul t  
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ho\.\ ed a reduct ion i n  the i n fection \.\ i th H. pylori i n  mo t developed countries, and 
i para l le led \ i th 10\\ inc idence of duodenal u lcer and ga tric cancer. 
Variety of extra d ige ti e di rder In the past few years, i nc lud i ng 
re p irator d i  ea e . card iovascu lar, sk i n  rheumatic and I i er d i  ea es have been 
di co ered to be a oc iated v i th H. pylori i n fect ion .  The pathogenetic mechan i m 
of thi ba teria i due to the act i at ion of i n flammatory mediators which underl ing 
the obser ed a oc iat ion between H. pylori i n fect ion and respi ratory d i  eases. A 
ma l l  number of epidem iologica l and serological case control studies suggest that 
H. pylori i n fection ma be a oc iated w i th the deve lopment of chron ic bronchit is .  A 
frequent pre ence of pulmonary tubercu los i s  and H. pylori i n fection has a l so been 
found ( Rousso ef al., 2003 ) .  
A i t  w as ment ioned before that H. pylori i s  an important factor of chronic 
gastr i t is  d i  ease (Norm ark ef al. , 2003 ; R i nta la el al., 2004).  Ga tri t i s  i s  a tenn 
v,hich can be defined a an infil trat ion of the t i ssue w ith lymphocytes and p lasma 
ce l l s .  The e bacteria can make i n fection b secret ing large amounts of urease, which 
hel ps i t  to sur i e in the highly ac id ic  env ironment of the tomach. About 50 
percent of a l l  stra i ns  produce cytotoxins, some of which (e .g., cag A tox in )  are 
assoc iated wi th gastr i t is  and u lcerat ion ( Fig. 1 . 1 ) . These cytotoxins  cause local 
i nflammat ion, resu l t i ng in a weaken i ng of the gastric mucosal barr ier that can lead 
to further t i ssue i njury. 
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Fig. 1 . 1 :  Photograph of an u lcer i n  the stomach as seen on upper endoscopy. 
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Decrea ing i n  ga tric ju ice a corbic ac id Ie e Is, � h ich are thought to be a 
pred i po ing factor for ga tric u l ceration and po ib l  ga tr ic  cancer, i s  a l  0 a resu lt  
of H. pylori i n fection (K leef e/ al. , 2003 ) .  
H. pylori erad icat ion remains an important publ ic  hea lth cha l lenge e pec ia l ly 
i n  l i ght of broaden i ng ind ication and increas ing ant im icrobia l  resistance (Cava l laro 
el al. , 2006) .  Eradication of the organ i m p lay a ro le i n  the accelerat ing the ulcer 
hea l i ng and al 0 prevent long-term u lcer re lapse . ow a day, two ant i biotics have 
been demon trated to ha e a high erad ication rates (greater than 90%) based on the 
erad icat ion regImens u ing  proton pump inhib i tor (PP I ) .  Amoxic i l l in ,  
c larithromyc in ,  and metron idazole are the most frequent ly used ant ibiotics for the 
treatment of H. pylori i n fe t ion .  However, ant ib iot ic re i stance frequentl causes 
fa i l ure of erad icat ion of H. pylori ( Kato et at. , 2002) .  The res istance of H. pylori to 
the recent ly ava i l able ant ib iot ic treatmen t  regimens has been a grow ing problem. 
About 1 0% to 1 5% of the adu l t  i nfected with H. pylori ha been found in the 
deve loped countrie as a metronidazo le res i stance, whereas v i rtua l ly a l l  stra ins  have 
been found in the deve loping countries wi th h igh rate of res istant for this drug ( Kato 
et al., 2002) .  On the other hand, the rates of c larithromyc i n  res istance were 
re lat i ve ly low, rang ing from 2% to 1 5%, where as nowadays c larithromyc i n  
resi tance has increased ( Kato e t  al., 2002) .  
A few stud ies were done i n  the U n i ted Arab E m i rates to study ant ib iotic 
res istance for H pylori. One of these studies was done in Zayed M i l i tary Hospital 
(ZM H )  and showed that: 65.5% of H. pylori were mutated for c lari thromyc in  
an i t i b iot i c  by Real t ime PC R techn ique, which ind icate high percentage of 
res i stance for thi s  ant i biot ic  (A I -Faresi et al., 2007).  
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1 .2 .  Pathogene i of H. pylori 
He !i obaeter pylori ha e a unique t of i ru Jence factor that a I JO\\ i t  to 
01 n ize the tomach w al l  ( Fig. 1 .2) .  The e fa tor i nc lude urea e, he l icoidal shape, 
flage l Ja. adhe ion and pro- i n flammator mo lecu le ( Bernard et al. ,  2004). 
Helicobacter pylori 
- \1Ie bat terlum causing peptic ulcer dlseas .. 
Infection 
Hfo "'Ooa r� P, " 
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Fig. 1 .2 :  Process of H. pylori pathogenesis 
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The ab i l i ty f H. pylori to colon ize the human tomach can be attri buted to the 
pr duct ion of pe i fi bacterial pr duct uch a urea e enzy me and se era l  outer 
membrane protein , in lud ing Bab , ab , IpA, Ip B, and HopZ. Be ide these 
product nage l l a  factor, perm it bacterial mot i l i t , wh ich a l lo \ bacterial penetrat ion 
of the mucu  layer ( Fig. 1 .3 )  ( Eaton and Krak m, ka, 1 994; Eaton el al. , 1 996 ) which 
lead to the act i  at ion of numerou igna l ing pathways that perm i t  ef fic ient del ivery 
of toxi n  or other effector molecules i nto the ce l l s  (Gu i l lem in  et al. ,  2002) .  
H. pylori has man mechani  ms to evade imm une system. One of these 
me han i ms is ant igenic di gu i se in which bacteria are coated w ith host prote i n  
(Jon son e l  aL 2004), other mechanisms may i nvo lve phase variation of  surface 
component . Membrane prote ins and l i popoly accharide ( L PS)  ant igens has been 
reported a pha e variation for mu l t i p le H pylori urface components (Appe lmelk et 
al. . 1 999). For examp le, H. pylori stra ins express LP 0 ant igens that are 
structura l l )  re lated to lewi blood group ant igens found in human ce l l  . Th is  
s im i larity in tructure between H. p) lori L PS and lew is  b lood group ant igens may 
represent a form of molecu lar m im icry that a l lo v s H. pylori LPS ant igens to be 
h ie lded from i mmune recogn i t ion because of s im i l arity to se l f  ant igens (A lgood 
and Cover, 2006). 
One o f  the most important pathogen ic  factors present in H pylori i s  40 Kb 
region o f  chromosoma l  D A known as cag pathogenici ty i land ( PA l )  (Akopyants 
et al., 1 998). The pathogen ic ity i s land conta i n  genes that enable the bacterium to 
cause ce l lu lar damage (Yang et al. ,  2004; Zhou el al. , 2004) .  Some stra ins conta in 
an i ncomplete cag PA J ( less than 40Kb i n  s ize) and i n  other stra i n s the cag PAl  is  
completely absent (Cens in i  el af., 1 996). From d i fferent stud ies, they found that  cag 
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PAl po i t ive tra i n  ha e a eriou ro le i n  the t imu lat ion of ga tric epithe l ia l  ce l l  
to produce h igh I e  e l  o f  pro i n flam matory c)10k ines ( kopyyant e t  al., 1 998; 
Brandt ef aI., 2005 ; A lgood and Cover, 2006 ). 
CNl�O (urea) 
I 
Urease +H20 t 







, SabA, SabA, AlpA, , AlpS, and HopZ 
/' 
r 
Fig. 1 .3 :  Colon izat ion factors of H. pylori. M u lt ip le bacterial factors contribute to 
the abi l ity of H pylori to colonize the stomach .  U rease contributes to the ac id 
res istance of H pylori. F lage l la perm i t  bacterial mot i l i ty which a l lows bacterial 
penetration of the m ucus l ayer. Several outer membrane prote ins, i nc lud ing BabA, 
abA, A l pA, A l p 8, and HopZ, can med iate bacteria l  adherence to gastric epi the l ia l  
ce l ls .  
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1 .2. 1 .  Cag A (Cy totoxin A sociateel Gene A)  
y!o!oxil1 a 0 ialed gene A (Cag ) i one of  the  mo t i ru lent product of 
40kb D fragment corre pond ing to 25 genes i n  s me tra i n  and 27 genes i n  
other , \\ here the e gene cal led the cag pathogen ic i ty i s land ( PA l ) . Th i s  bacterial 
e f fe tor prote i n  (Cag ) wh ich i encoded by Cag A gene (one gene of the ag PAr) 
tran locate i nto the ga tric epithe l ial ce l ls and induces numerous al terat ions in 
ce l l u lar igna l i ng ( sah i  el al., 2000; H iga h i  el al., 2002). Mu lt ip le other products 
of cag P [have been found to p lay a ro le i n  secretion of cag A and in  al terat ion of 
gene transcript ion in gastric epithel ia l  ce l l , for example the cag PAl in H. pylori 
_6695 stra in  i cons i  t of 27 putat i e genes, Seventeen out of 27 genes were found 
to be ab ol ute l)  es ent ial  for trans locat ion of Cag A in to host ce l l  ( F ischer el al., 
200 I ) . 
Many re earcher i n  e t igating  cag A gene have shown that i n fection with 
po it i  e cag A H. pylori tra i n  i nc rea es the v iru lence of the bacteri um .  Stri k i ng 
e i dence shows that 88% - 1 00% of pat ients wi th u lcers were i nfected by cag A 
pos i t i  e stra i ns; and about 50% - 60% pat ients i n fected by cag A negat ive stra ins 
de e loped u lcers. A lso they found that  pat ients w i th cag A ant ibod ies, had the 
abi l ity to develope gastric cancer ( Holeston, 2004) .  
A l though the  actual  ro le of t he  cag A gene is  unknown, many studies currently 
show an i ncreased risk for develop i ng u lcers and gastric cancer assoc iated with cag 
A-posi t i ve stra ins  (Holeston, 2004) .  
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1.3. C l i n ical  Aspects of H. pylori A sociated Disease 
a fact colon ization with H. pylori i not con idered a a di ea e however, 
condi t ion that affect the re lat i e ri k of de e loping variou l i n ical d isorders of the 
upper ga tro inte t inal tract i a di ea e (Ku  ter et a I . ,  2006) .  
E \  en though ga tr ic  colon ization \ i th H. pylori induces h i stologic ga tr i t is i n  
a l l  i n fected i nd i  iduals, onl)  ery fe\ people de e lop any apparent c l i n ical igns of 
thi colon izat ion.  About 1 0% to 20% l i fetime risk of deve lop ing u lcer d i sea e and a 
1 % to 2% ri k of de e loping d i sta l ga tric cancer have been est imated i n  H. pylori-
po i t ive pat ient (Ku iper ef a/., 1 995 ;  Ku ipers, 1 999; Ernst and Gold, 2000). The 
r isk of development of these d isorders in the presence of H. pylori i n fection depends 
on a ariet) of bacterial stra i ns, host, and en i ronmental factors that most ly re late to 
the pattern and severi ty of gastri t i  ( Fig. 1 .4 )  ( Kusters et a I . , 2006) .  
EnvIronmental factor.; 
(sm:>uI'g alcohol. NSAIO. 
"PI' 
H. pylori 












Fig. 1 .4 :  Schemat ic  representation of the factors contr ibut ing to gastric pathology and 
d i sease outcome in H. pylori i n fect ion .  
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Acute a n d  c h ronic ga tr i t i  : gastr i t i  can be de f ined a i n f i l trat ion of the 
ga tric m uco a in b th antrum and corpu ith neutroph i l ic and mononuclear ce l l s  
a a re u l t of H. PJ'lorj colon izat ion (Ku  ters e t  a I . , 2006) .  
Peptic u lcer d isea e :  ga tr ic  or duodenal u lcer (common ly referred to as 
pept ic u lcer ) are defi ned a muco al defects wi th a d iameter of at lea t 0 .5  cm 
penetrat i ng through the  m u  cu lari m ucosa. Gastric u lcers most ly occur along the 
Ie er curvature of the tomach,  in part icu lar, at the tran i t ion from corpus to antrum 
m uco a (Veldhuyzen van Zanten e/ 01., 1 999). Duodenal  u lcers usua l ly occur in the 
duodenal  bu lb. \\ h ich i the area most exposed to ga tric ac id ( Kusters et a I . ,  2006). 
Non - u lcer dyspepsia : funct ional dyspepsia is defined as the presence of 
ymptoms of upper ga tro intest i nal d i stress w ithout any ident i fiable structural 
abnonna l i ty dur ing d iagnost ic  work-up, 111 part icu lar inc lud i ng upper 
gastro in test i na l  endo copy. Dyspept ic  symptoms may have a reflux- l ike character, 
w ith heartburn and regurgitat ion as predom i nant igns; may appear dysmot i l i ty- l i ke, 
with early satiety and nau ea; or may be u lcer- l i ke, wi th pa i n  and vom it ing ( Kusters 
et a l . .  2006) .  
Atroph ic gastrit is,  i n test i n a l  metaplasia,  a n d  gastric ca ncer: loss o f  the 
nonnaI gastric m ucosa l arch itecture, wi th  de truct ion of gastric glands and 
rep lacement by fi bros is  and i ntest i na I - type epithe l i um  are the results of chronic 
inflammat ion induced by H. pylori. Th is  process of atroph ic gastr i t is  and i ntest i nal 
metaplasia occurs in approxi mately ha lf  of the H. pylori-colon ized popu lation, fi rst 
in those subjects and at those s i tes where i n flammation i s  most severe (Ku ipers e/ 
al., 1 995b) . The risk for atroph i c  gastr i t i s  depends on the d i str ibut ion and pattern of 
chron ic  act i ve i n flammat ion . As such, subjects wi th decrea ed ac id output show a 
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more rapid progre ion toward atrophy (Kuiper ef 01., 1 996) ( Fig. 1 .5 ) .  Areas of 
gland 10 and inte t inal metapla ia extend \ ith time; they increa e the ri k for 
ga tri c  cancer b 5 - to 90-ft Id depending on the e ·tent and severity of atrophy 
( ipponen er 01., 1 985 ) .  
Pattern of Gastric Duodenal Acid Clinical 
gas trlUs hIstology histology s ecretion con dition 
J) 
· ChroniC 
InnammatJOn · Normal . Reduced · Gastnc ulcer 





· ChroniC · Gastric . Increased · Duodenal ulcer 
Innammation metaplasia 





Fig. 1 .5 :  Acid secretion and the a ociated pattern of gastriti p lay an important 
ro le in disease outcome in H p ylori i n fection . The figure displays the corre lations 
between the pattern of H p ylori colonization. i n flammation, acid secretion, gastric 
and duodenal histo logy, and c li nica l  outcome. 
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Ga t roe ophagea l refl u x  d i  ea e (GERD): ha long been considered to 
occur i ndep ndent ly of H pylori col n izat ion, i .e . ,  to occur ith the ame frequency 
and everi t} in H. pylori-po iti e and H pylori-negati e ubject . Thi opin ion wa 
ba ed on cro - e t ional ob er ation " h ich sugge ted that the prevalence of H 
pylori among G E R D  pat ient was im i lar to that among contro ls  ( Werdmul ler and 
Loffe ld, 1 997) .  Howe er, further studi ugge ted that H pylori m ight protect 
aga in  t the d e lopment of GERD and a such a lso be of benefit to the i r  hosts 
(Ku  ter et a I . , 2006). 
Gastric M A LT ly mphoma.  The ga tric m uco a does not norma l ly conta i n  
I) mphoid t i s  ue, but M LT nearl ah ay appears in response to colon izat ion with 
H. pylori. In rare ca e , a monoc lonal popUlat ion of B cel l s  may arise from th is  
t i  sue and s lowly pro l i ferate to form a M A LT lymphoma ( Kusters et  a I . ,  2006) .  
1 . 4. Diagnosis of  H .pylori 
H p.vlori i n fection can be d iagnosed by invas ive techn iques reqU I ring 
endoscopy and b iopsy ( Ex :  h i sto logical  exam ination, cu lture, polymerase chain 
react ion) and by non- l I1 aS lve techn ique such as erology, urea breath test, 
ur inelblood test, or detect ion of H .pylori ant igen in stool spec i men (Nakata et a I . ,  
2004).  
1 .4. 1 .  Non - I nvasive Tests 
A number of non invas ive tests have been developed to establ ish the presence 
of H pylori i n fect ion . A l though polyclonal ant i body-based stool ant igen test ing has 
a good sens i t iv i ty and spec i fic i ty, it is less accurate than urea breath test i ng. 
Recently. a monoc lonal ant i body-based stool antigen test demonstrated an excel lent 
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perfonnance i n  d iagno i ng H. pylori i nfection i n  adu lt and i n  ped iatric popu lat ion 
( 0  re el al .. 2004) .  The tw o ma in  techn ique for thi d iagno i are serology and 
urea breath te t. 
1 .4.2.  I nva ive Te t 
I n  a i e d iagno i requ i re endo copy of a pat ient, during which biop ie are 
taken from m u l t ip le i te i n  the e ophagu , stomach, and duodenum.  The most 
popu lar te t is the b iop urea e test. Th i s  test check for the pre ence of the 
enz) me urease i n  the b iop y t i ssue sample .  A Gram sta i n  of a biopsy sample can be 
made. The G iem a ta in can a l so be u ed for detect ion of the organ ism . A b iopsy 
a lso a l low for a bacterio logical  cu lture of the ample .  A cu lture a l lm s for the 
detenn ination of ant ib iot ic sens i t iv i ty .  A l so \ e can use h i stology, bacterial cu l ture 
as i nvasive test Giemsa sta i n  demonstrat i ng colon ization of the gastric m ucosa by H. 
pylori ( K i m  el at. , 2004 ; N i m i  h e/ at. , 2004) . 
1 .4 .2 . 1 .  Rapid U rea e Te t 
I t  i s  a w idely used test i n  endoscopy room for rapid detect ion of H. pylori 
i n fection ( Haze l l  et aL, 1 987). The mode of action of th is  test is a fol low : A gastric 
biopsy samp les from antrum are p laced in urea broth (5% urea sol ut ions w ith phenol 
red). I f  there is any urease produced by H. pylori in b iopsy spec imen, the urease \i i l l  
then hydrolyze urea i n  broth to ammon i um ion . Th is  w i l l  ra ise the p H  which can be 
detected by the color change from yel low to red due to the presence of the phenol 
red as i nd icator. I n  true pos i t ive resu l ts, 75% of the broth wi l l  turned red in  20 
m inutes and 90% wi th in  3 hours.  Commerc ia l  rapid urease test are avai lable, the 
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fir t one kno\\ n a LO te t ( LO= Call7pylobacler Like Organ ism) (Wong el of. ,  
1 997) .  
Rapid urea e test ha a l i m i ted en i t iv i ty (70-90%), th i  sen i t iv ity reduced 
a ft r erad i ation therap . Fal e po i t i ve may Occur after 24 hours due to other 
urea e p i t ive organ i  m i n  the ga tric biop y. A a re u l t  th is  test hould be read 
\\ ith i n  24 hour . I so fa l se negat i e have been reported i n  pat ients w ith recent 
i ntake of proton pum p  i nh ib i tor , b ism uth,  H2 receptor antagon ist or ant ib iotics 
da) s before the test ( Wong el 01., 1 997) .  
1 .4.2.2 .  Poly merase C h a i n  Reaction 
Pol)  merase cha in react ion ( pe R )  can be defined as an enzymat ic process in 
\\ h ich spec i fic region of 0 A i s  repl icated over and over aga in  to y ie ld many 
copies of a part icu lar sequence. Th i s  molecu lar techn ique i nvolves heat i ng and 
coo l i ng amples in spec ific  thermal cyc l i ng pattern over 30 cyc les ( Fig. 1 .6 ) .  During 
each cyc le, a copy of the target 0 A sequence is  generated for every molecu le 
conta i n i ng the target equence. A fter 30 cyc les b i l l ions copies of the target region 
on the 0 A template ha e been generated and th i s  was calcu lated theoret ica l ly 
(Ta ble 1 . 1 )  ( B ut ler, 2005 ). 
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Fig. 1 .6:  PCR Process. A )  Thermal cy c l i ng temperature profi le for pe R :  Thermal cyc l i ng i m ol \ es 
three di fferent temperatures that repeated over and 0\ er again 25-30 t imes. At 94°C, the D A 
strands separate. or denature. At 60°C primers bind or anneal to the DNA template and target the 
region to be ampl i fied, At 72°C, The D A poly merase extends the primers by COP) i n g  the target 
region using the deox y n ucleotide triphosphate bui lding block. B) DNA amp l i fication process 
\\- i th in  the pol y merase chain reaction: I n  each cycle, the two D A template strands are fi rst 
separated b) heat. The sample is then cooled to an appropri ate temperature to bind "anneal" the 
ol igonucleotide primers. F i nal l y  the temperature of the sample is raised to optimal temperature for 
the D A pol) merase and it extends the primers to produce a copy of each D A template strand. 
For each C) cle. the number of D A molecules doubles. 
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Table 1 . 1 :  umber f target D molecu le created b P R ampl i ficat ion.  
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8388608 
1 67772 1 6  
3 3 5 5443 2 
67 1 08864 
1 342 1 7728 
26843 5456 
53 68709 1 2  
1 073 74 1 824 
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P R ha been kn \\ n for its h igh en i t i  it) and pec i fic i t . I t  \ a u ed a 
d iagn ti tool i n  c l i n ica l  fie ld. For example PC R i used no\ aday for the 
detect ion f H pylori 0 in bod i l  material uch a b iopsie , fece and sa l iva. A 
spec i fic egment f D from H pylori can be amp l i fied . The primer u ed 
rout ine l  are deri ed  from 26 KDa ant igen gene, Urease C gene ( Labigne e t  a l . , 
1 99 1 ) . Other ma u e Cag A gene for PC R ( Wong el 01. , 1 997) .  
1 .5. H. pylori E radication 
Man) ant im icrobia l  agents have been tud ied for the ir  efficacy i n  erad icat ing 
H pylori i n fection ei ther a a i ngle agent or a a combination therapy .  In  fact s ing le 
ant im icrobia l  agent treatment schedu les have not been uffic iently effect ive w i th 
erad icat ion rates ranging from on ly 23% for amoxic i l l i n  to 54% of c larithromyc in  
(Ch iba e f  01. , 1 992 ;  Peterson e f  01., 1 993) .  S ingle drug regimens are not advocated 
due to potent ia l  for the deve lopment of ant im icrobial res i  tance espec ia l ly to 
macro l ides and n itro im idazoles, \ h ich are the key agent in mu l t i  drug regimens for 
H .  pylori ( Kate. V and Ananthakrisshnan.  N,  200 1 ). Dual treatment combin ing a 
proton pump inh ib i tors ( PP l s) wi th e i ther c larithromyc in  or amox ic i l l i n  were 
popu lar a few y ears ago ( Kate. V and Ananthakri lman. , 200 1 ) . PP l s  are drugs 
that covalently b i nd and i rrevers ib l  i nh ib i t  the H+ /K+ adenosine triphosphatase 
(ATPase) pump, effect ively inh ib i t i ng acid re lease . Omeprazo le ( Pri losec ), 
lansoprazole ( Prevac id ), rabeprazo le (Ac iphex), and pantoprazole ( Proton ix) g iven 
in da i ly  or tw ice-dai ly doses for 4 weeks heal 80- 1 00% of gastric u lcers if H pylori 
i nfection i s  not present or has been erad icated ( Wa lker. R and Edwards. C, 2003 ) .  
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lot of tr iple drug th rapy had been u ed (Table 1 .2 )  and the recent one is 
con i t of g i  ing ran i t id ine b i  m uth c itrate ( R B  ) , c larithromyc in  and 
metr n idaz Ie. The e combination produce Ie acid suppre sion but prov ide the 
add i t ional ant im icrobial action of b i  muth ( McColm el al. , 1 996) .  
Effort have been made to ach ie e 1 00% eradication of H pylori by using 
Quadruple therapy by add it ion of ant i  ecretory agent to the c l assic b ismuth based 
tr iple therapy (Ta b le  1 .2 )  ( Kate . V and Ananthakr isshnan . N, 200 1 ) . 
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Table 1 .2 :  Regimen ft r erad ication of H pylori 
Regimens Dosage 
Omeprazole 20 mg b l  d 
Clonthromycln 500 b l.d 
Colloidal Bismuth ubcltrate (CBS) 1 20 mg q rd 
Tetracycline 500 mg, q rd 
Melronldazole 400 q I d 
Omeprazole' 40 mg a d  
moxlcillin 500 mg, ( I d  
etronldazole 400 mg, II d 
Omeprazole' 40 mg, a d  or 20 mg, b.1 d 
Clanthromycln 250 mg, bid 
Metronidazole 400 mg, bid I( I d 
Omeprazole' 40 mg, ad or 20 mg bid. 
AmoXICIlhn I g bi d 
Claflthromycln 250-500 mg, b i d  
Omeprazole 20 mg, a d. or bid 
CBS 1 20 mg q rd. 
Tetracycline 500 mg, qrd 
Metronidazole 400-500 mg, q Id or l rd  
Ranllidlne bismuth citrate 400 mg b l.d 
ClanthromYCIn 500 mg, bi d 
Metronidazole 500 mg, b.l.d.lUd 
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Duration H flIlon 
eradication 
2 weeks 60-8000 
2 weeks 30·95% 
1 -2 weeks 75-90°0 
1 -2 weeks 85-95°10 
1 -2 weeks 85-9500 
1 week 86-98°/0 
7-14 days > 90% 
1 .6. Ant ibiot ic Re i tance 
1 .6. 1 .  M etron idazole M ode of Action 
i tr im idazole J)  u h a metron idazole is  w idel u ed for H. pylori and 
other ana robic bacteria treatment (Jenk and Ed\ ard , 2002). It enter the ce l l  by 
pa i e d i ffu ion (Jenks and Edward , 2002 ; Van Der Wouden et al. , 2000 ). The 
ant im icr b ia l  tox ic i ty of th i  drug is dependent on the reduct ion of n itro moiety to 
other compound l i ke n i tro an ion rad ical ,  n itroso and hydroxyl amine derivates 
( L i ndmark and M u l ler, 1 976; Moreno et al., 1 983) .  These reduct ion products w i l l  
cau e D A degradation and a l so i t  damaging other macromolecu les (Jenks and 
Ed\" ards. 2002). 
Jenks and Edward (2002) reported that the select ive to ' ic i ty of metron idazole 
i n  anaerobic bacteria i due to the redox potent ia l  of the electron transport chain 
components which are negat i  e to reduce the n i tro group of th is drug. W ith in  these 
m icroorganisms electron can be produced by decarboxylat ion of pyruvate which 
passed on to ferredoxin  or flavodoxin .  (Sm ith and Edwards, 1 995), these low redox 
e lectron carrier prote ins w i l l  then reduce another component, most ly a proton, 
which work as term inal e lectron acceptor (Jenks and Edwards, 2002) . I n  fact 
metron idazole has very low redox potent ia l  and was reduced by accept ing electrons 
from reduced ferredoxin  or flavodox in  ( Edwards et al., 1 973 ; Edwards, 1 993a) .  The 
cont inu ing  reduction of th i s  drug mainta ins a favorable transmembrane 
metron idazo le concentration gradient fac i l itat i ng  further d i ffusion of the drug to the 
ce l l  ( l gns  e/ al. ,  1 974). 
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a in l} Metron idazole can be metabol ized i n  anaerobic bacteria by two 
mechan i  m : The fi r t one knm'v n a O>..y gen- in en i t i  e n i toreductase ( Fig. I .7 )  
( an Der Woud n et 01. . �OOO ) .  
N I )J" I 2 - c:===> D N A  d a m a ge D� repail 
t 
Fig. I .7 :  Metabol ism of a n itro im idazole (N I )  by an oxygen- i nsensi t ive 
n itroreductase .R  represents the electron donor e represents an electron . 
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OX) gen- i n  en i t i  e denote the reduct ion of metronidazole re u l ts i n  a n i tro 0 
deri ate by imu ltane 1I tran fer of two e lectrons (Van Der Wouden ef 01. , 2000). 
The product \\- h ich re u l ted from th i  tep can ' t  be reox id ized by molecu lar oxygen 
and the n i troredll ta e fac i l i tat ing the t\ 0 electron transfer step, therefore, ca l l ed 
o:\.) gen i n  en i t ive (Van Der Wouden e/ aI. , 2000). 
Th second mechani  m of act ion were i t  is cons idered as an a l ternat ive 
mechan i sm when anaerobic bacteria are exposed to aerobic atmosphere cond i t ions 
i through ox gen en i t ive n i troreductase ( Fig. 1 .8 )  (Jenks and Edwards, 2002) .  
o� 
O T l d o r . d � c .· S 6  
N I  i�> _ I '  
R - e - R 
H 20 
S O D  n-O J  i�HJ0 1 
� ==> D 1\ A  
d a m a g. e  D. ¢:::= rep a i l  
t ?  
Fig. 1 .8 :  Metabo l ism of a n itro im idazole (N I )  by an oxygen-sens i t ive 
n itroreductase. R represents the e lectron donor, e represents an e lectron .  SOD 
represents superoxide d ismutase. 
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I n  th i  pr ce metronidazole i reduced b) one e lectron tran fer tep to to ic 
free rad ical an ion that can be metabo l ized b one of the fol low ing two 'V ays: I )  Free 
rad ical an i  n can be reoxid ized to the origi na l  compound by molecu lar oxygen with 
pr duct i  n of supero ' ide. Thereby, mole u lar  0 'ygen reverts the reduct ion step and 
the e n itroreducta e are therefore cal led 0 ygen- en i t i  e (Van Der Wouden et aI. , 
2000). Thi  proce s of reduction and reo idat ion is  repeated end lessly and cal led 
" fut i le cyc l i ng" ( Docampo and Moreno, 1 986). A l though thi cycle results in the 
detox ification of the drug, it a l so generates superox ide rad ical an ion that maybe 
toxic to the m icroorgan i  m . ( Docampo and Moreno, 1 986) .  The superoxide 
produced dur i ng th i s  cycle can be e l im inated by the act ion of superox ide d ismutase 
vv h ich generates hydrogen perox ide wh ich is further reduced to water by the 
catala e enzyme. ( Edwards, 1 993a).  The second way to metabol ize the toxic free 
rad ical  an ion is another e lectron transfer step i n  the presence of trans i t ion e lement 
uch as i ron and copper which convert the free rad ical an ion to more toxic 
substances wh ich lead to D A damages (Van Der Wouden e/ al. , 2000) .  
Anaerobic bacteria deve lop res i stance to metronidazole by reduc ing act iv i ty of 
e lement of this eries of e lectron transport reaction POR and ferredoxin  w i th 
appropriate modification of the normal  fermentat ive pathway (Narikawa, 1 986; 
Quon el aI. , 1 992: Edwards, 1 993b; Townson et aI., 1 996; Wassamann el al., 1 999). 
On the other hand the very low redox potent ia l  of metron idazole prevents its 
reduction by aerobic bacteria and th i s  exp la ins  the ir  i ntr ins ic res i stance to th i s  drug 
(Jenks and Edwards. 2002 ) .  
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1 .6.2.  M et ron idazole Re i tance in  H. py lori 
I t  \ a propo ed that the rea ti e 0 'ygen pec ie generated b fut i le cyc l i ng 
vvere re pon ib le  for ce l l  death i n  H. pylori and th i  i s  due to the environment 
ond i t ion v" here the e bacteria I i e ( Lace et a I . ,  1 993) .  A lot of research were 
dev ted to demonstrate the pre ence of th i  process in  H pylori but  a l l  these efforts 
fa i l  d becau e no uccessfu l  resu l t were found ( m ith and Edwards, 1 995 ;  
Jorgensen el  01. , 1 998) ,  \ here they found that supero ide  d i smutase and catalase 
(\\ h ich are enz mes produced during oxygen sensi t ive process) are not i nduced by 
metron idazo le and there i s  no corre lat ion between enzyme leve ls  and res istance 
patterns ( m ith and Ed\ ards, 1 995 ) . Therefore, l i tt le ev idence that fut i le cyc l ing 
contr ibutes to the mode of act ion i n  H. pylori. On the other hand the observation of 
the pre-exposure of many metron idazole-re i tant stra i ns to anaerobic condit ions 
\\ h ich resu l ted in the loss of the resi tant phenotype was the early ind ication that the 
act i v i ty of metron idazole i n  H pylori dependent on reduct i ve activat ion ( m i th and 
Edwards, 1 995 :  Cederbrant et 01., 1 992) .  Th i s  means that the suscept ib i l i ty to 
metron idazole may be restored at 10 er oxygen tensions through the acti vat ion of 
lov" er redox potent ia l  anaerobic reduct ion pathway which function less, or not at a l l  
under m ic roaerobic env i ronment. Furthermore, I t  was found that metron idazole 
res istant H. pylori have reduced act i v i ty of N A DH oxidase (Smi th and Edwards, 
1 997) wh ich  is thought to act as an oxygen scavenger, reduc ing the in trace l l u lar 
oxygen tens ion and ma inta i n ing a low redox status at the i te of metron idazole 
reduct ion. Low level of ADH ox idase act iv ity in res istant stra ins  may compromise 
oxygen scavenging, a l lowing the redox potent ia l  to r ise sufficient ly to prevent 
act ivat ion of metron idazole (Jenks and Edwards, 2002) .  
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e era l  tud ie on fre h c l i n ical  i olate ind icated that metronidazole re i tant 
m tl) re u lt from point mutat ion in  the rd-x:A gene, a g ne that encode an 0 ygen-
in en i t i  e DPH n i troreducta e. H igh leve l of res i  tance to metronidazole is  
attri butable to mutat ional inact i  at ion of rd'CA gene ( Debet -0 enkopp el al., 1 999).  
I though the knock out of the enz) me encoded by this gene re u l ts  in  re i stance, the 
acti i t) of other enz me , as wel l  a the abi l i ty of the stra ins  to neutral ize the toxic 
metabo l i tes and repai r  D Damage ma re u l t  i n  background variation in  
u cept ib i  I it) . I t  i s  therefore, not unexpected that large variation i n  the m in imal  
i nh ib i tor) concentrat ion ( M IC )  are een both i n  any uscept ib le and resistant 
i o late (Graham, 1 998 ;  Van Der Wouden el al. ,  1 999a; Van Der Wouden el al. ,  
1 999b). 
F i na l l i t  w as found that the absence of functional rd-x:A encoded 
n it roreducta e cause no sur i al di advantage of m ic roorgan i sms in the absence of 
th i  ant ib iot ic  (Good\ i n  el  al., 1 998) .  So  res istant m utants may pers ist for decades, 
often coexi t i ng with suscept ib le  organisms (Tay lor el al. , 1 995) .  
1 .6.3. Clar i th romyci n Mode of Action 
Macrol i de mechani m of act ion has been stud ied for more than 30 years but 
is  st i l l  unc lear. A l l  macro l ide i nh ib i t  bacter ia l  prote in synthes i s  to vary ing extents 
(Mazzei et al . .  \ 993 ) .  One of these macro l ides is c l ar ithromyc in  which is act ive 
i ntrace l l u larly, and its action i s  stat ic  or bacter ic ida l .  depend ing on the organ ism and 
ant im icrobia l  agent concentrat ion (Anderson e/ aI. , 1 993 ) .  
1 .6.4. C lari th romyci n  Resistance i n  H. plod 
Poi nt m utation from aden ine (A)  to guan ine (G)  i n  the 23S rRl\fA gene is the 
main  reason for c larithromyc in res i stance in H. pylori ( Fig. 1 .9 ) .  An aden i ne (A) to 
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guan ine (G tran i t ion mutation wi th in  a c n er ed loop of 23S rRNA of H. pylori 
and i t  a oc iat ion \\ i th c larithromyc in  re i tance wa fi r t ident i fied by Versa lov ic 
el  a1, (Ver alo ic  el al. , 1 996). 
The mutation 0 cur common ly at two po i t ion 2058 and 2059 in Escherichia 
coli-23 rR.i A ,  .... h i le in  H pylori the mutat ion oc urs a t  pos it ion 2 1 421 2 1 43 
formerly kno\', n a p i t ion 2 1 4312 1 44 ( Fig 1 . 1 0 )  ( Megraud, 1 998;  Taylor ef aI., 
1 99h Point mutation ma occur at other po i t ion , and can be a transi t ion (A G) or 
a tran ersion (A ), but the transit ion is far more frequent ( Megraud, 1 998 ·  
Ver alovic ef al. . 1 997; H u lten et aI. , 1 997) .  Furthermore, A2 1 42G mutation was 
as oc iated \\ ith a h igh Ie el  of re istance ( M I  >64 mg/L) than the A2 1 43G 
mutation as Versa lo i et aI. ,  1 997 found. 
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Fig. 1 .9 :  Ba e sub t itut ions i n  23S rRNA confer resi stance to macrol ides 
Fig. 1 . 1 0 :  Doma in  V loops of the 23S rRNA molecu les from H pylori UA802 
and E. coli. 
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The e ob er ation are upported b) other tud ie ( tone et aI. , 1 997; Wang 
and Ta) lor, 1 998) .  Add it iona l ly,  macr l ide-resistance ha been reported a unstable 
in orne tra i n  of H. pylori in vitro and in l'ivo where tra i n  de e loped resi tance 
po t-treatment and then r erted to be ing u cept i ble a fter a I eriod of fol low up 
( ia el 01. , 1 996; Ver a lo IC et 01. ( 996). Cross-resi stance between macrol ides i n  H. 
pylori has been ob er ed ( M idolo ef 01., 1 997;  Xia  et 0/. , 1 996. Versa lov ic et 01., 
1 996). Common l) , H. pylori stra in  re istant to  c l ar ithromyc in are a l so res istant to 
efJthrom) c in and az i thromyc in ( Wang and Taylor, 1 998) .  
ew approach for d i agno ing macro l ide res i  tant H. pylori stra ins  have been 
tarted through the a soc iat ion between point  mutat ions on the 23S rRNA gene and 
macrol ide res i stance in H pylori. Cyc le 0 A sequenc ing of the 23S rRNA gene 
ampl icon i cons idered as the reference method, however, s impler techn iques have 
been deve loped (Megraud, 1 997) .  These inc l ude polymerase cha in  react ion based 
restrict ion fragment length polymorphism ( PCR-RFLP), an o l igonuc leot ide l i gation 
assa) ( PC R-OLA), a 0 A enzyme immunoassay ( PC R-DEI A),  a reverse 
h) brid i sat ion l ine probe assay ( PC R- L i PA ), and a preferent ia l  homoduplex 
formation assay ( PC R-PHFA )  ( Versa lov ic et 01., 1 996; Taylor et 01., 1 997;  Stone et 
01., 1 997 ;  Pina et aI. , 1 998; Maeda el 01. , 1 998) .  Molecu lar techn iques such as PCR 
are qu icker than m icro b iologica l suscept i b i l ity test i ng, and more important ly, they 
can be perfonned d i rect ly on gastric b iopsies and gastric Ju ice ( Maeda et aI. , 1 998; 
Bjorkholm el aI. , 1 998 ;  Sevi n  et al. , 1 998) .  
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1 .  7 Object ives 
The Objecti es of the pre ent tud) are : 
1 - creen ing of p pt ic u lcer patient i n  U E and test ing for the pre ence of H. 
pylori. 
2- Detenn inat i  n of th pre a lence of ant ib iot ic  resi tance genes (m utation in  
23 rRl 'A gene in c larithrom c i n, and deletion in RdxA gene I n  
metron idazole) among H. pylori tra i n  i olated from U .A .E  pat ients by 
u ing molecular method (pe R  and sequenc ing) .  
3- To a certa in  \ hether Cag A- posi t ive H pylori stra ins corre lates with the 
ant i b iot ic  re i tance tra ins  or not. 
�- We a l  0 creened for new H pylori tra ins i n  UAE through the phy logenetic 
anal)' i of the 23S rRNA m iddle region of the gene. 
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CHAPTER I I  
MATERIALS AND 
METHODS 
2 .  Material and Methods 
2. 1 .  a m ple Col lect ion 
From Ju l)  2008 to Januar) 2009, a tota l of 90 Ga tric b iop y amples were 
obta i ned from d) spept i pat ient referred for endoscopy departments i n  Zayed 
M i J i tar 1 10 pita !  (ZM H )  i n  Abu Dhabi, U E (mean age 40 years [ range 1 9- 80] ;  64 
male [ 7 1 . 1  %], 26 female [ 28 .9%] ) .  For each pat ient, one endoscopi c  biopsy 
spec imen taken from antrum of stomach and d i rect ly frozen at _20DC for further 
proce s i ng. The re earch were conducted accord i ng to appropriate ethical guide l i ne 
and appro ed by Deputy Commander at ZM H .  
2.2 .  DNA I so lat ion  
D A was i solated from 25-50 m g  thawed b iopsy t i ssue us ing QI Aamp DNA 
M i n i  k i t  (QIAGE , Cat 0:  5 1 306) accord ing to the manufacture 's  d i rection . The 
i o lated D A \ as e l uted in 60 ilL e l ut ion bu ffer and stored at - 20DC unt i l  further 
anal) i s .  
2.3.  Iden t ification of  H. pylori i n  B iopsy Sa m p les 
A l l  samples were i n it i a l ly  tested for H pylori i nfection w ith CLO test at the 
endo copy un it in Z M H .  To confi rm C LO test resu l ts, PC R ident i fication was 
carried out us ing species-spec ific  ant igen gene .  The fol low ing primer pai r  was used : 
ant igen spec ific  forward and ant igen spec ific  reverse (Table 2 . 1 ), primers were 
obtai ned from Operon.  The ampl ification of DNA was done i n  0 .2 m !  reaction tubes 
by PCR us ing a therma l  cycler (PERK IN ELM E R  2400).  50 JlI react ion m ixtures 
consisted I x PCR master m ix (QIAGE E, Cat  No: 20 1 445), forward and reverse 
primer each at a concentrat ion of 0. 1 JlM and 2 III from extracted DNA as a template 
where the best bands reso lut ion were at the concentration range from 1 00-200ng/1l1 .  
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ach reaction m i xture wa amp l i fied a fol lo\ (Table 2 .2 )  : denaturation at 94° 
for 5 and then the ample wa a l lO\ ed to undergo 40 cyc le \ J  h ich con i ted in  
denaturation of D for I m in at 94
0 




exten ion of primer fI r i m  i n  at 72 C .  fi nal exten ion of D A \ as carried out for 
o 
1 0  m i n  at 72 C to n ure complete ampl i ficat ion. equenced sample from posi t ive 
amp l i fied pe R products er ed as po it i e contro l  ( Fig. 2 . 1 ), \ here as, d i st i l led 
\c\ ater erved a a negat i e control dur i ng the ampl i fication. The ampl i fied D A 
product \\ as ana lyzed by e lectrophore is us ing agarose ( I n v itrogen, Cat No: 1 0975-
035) prepared i n  TBE (Tris Borate-E DTA) buffer ( 1 .5 g/ 1 00 m l ) . The s ize of the 
ge l \'v a l O x 7 cm \ i th a th ickness of 0.3 cm.  amp le  were loaded on  the ge l  and a 
vol tage of 1 00Y was appl ied. 1 00bp DNA ladder ( I nv i trogen, Cat No: 1 0488-058) 
wa used as marker to know the ize of the PC R product. The sample was a l lowed 
to run for I hr and the gel was ta ined with 0 .5  mg Im l eth id ium brom ide for 30 m in .  
The band was seen by i l l um inat ion w ith U Y  l ight i n  a gel documentation system.  
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Gene 
S pecie - S  pecific 
Aa nt igen Gene 
rcL� Gene 
23S rR 'A Gene 
Cag A Gene 
Gene 
Ss pecies-Sspecific 
A a n t igen G e n e  
rd� gen e  
23S rRNA gene 
Cag A ge n e  
Table 2 . 1 : Primer equen e u ed in this tud} 
Fo n\l a rd pri m e r  Reve rse pr imer  
5 "-TGG TGT r TT CG 5 "-CCTGCTGCG A TTCAC A TG-3' 
5'- ATlTG A fG JGG G -3 ' 5 ' -GAAACGCTTGAAAACACCCCT-3 ' 
. GTC GGA CT GGCG G-3 ' 5 'TTCCCG TTAGATGCTTTCAG-3' 
5 ' -ATA \TGCTAAATT GACA crr GCGA-3 ' 5 ' -AGAAACAAAAG AAT CGATCATTC-3' 
Table 2 .2 :  pe R programs to ampl i fy d i fferent genes 
PCR P rogra m ( fo l l owed by a I O- m i n  extension step a t  prod uct 
72°C) s ize 
40 cyc l es, denatured at 94 °e for 5 m i n , 94°e for 1 m in, 68°e for 1 298-bp 
m in ,  noe for 1 m i n  
3 5  cyc les. denatured at 9 4  °e for 5 m i n , 94°e for 3 0  s ,  55°e for 3 0  s, 850-pb 
noe for 30 s 
40 cycles, denatured at 94 °e for 6 m i n , 94°e for 30 s, 500e for 1 m in, 1 400-bp 
noe for 3 m i n  
5 0  cycles, denatured at 95 °e for 3 m in . 94°e for 1 m in ,  48°e for 45 s, J 28-bp 
noe for 45 s 
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Fig. 2 . 1 :  Sequenc ing  chromatogram for pos i t ive control used i n  the Ident i fication of H 
pylori by peR .  
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2.4. Detect ion of Cytotoxin Associated gene A ( Cog A )  
ag A gene \\ a cr en d by P R techn ique.  Primer for PCR ampl i fications 
\\ er de igned ba ed on pub l i shed equence for eag A gene (Table 2 . 1 ) .  Each P R 
\\ a performed \\ i th a ol ume of 50 II I conta in i ng L x PC R master m i  , forward and 
r ver e primer each at a concentration of 0 . 1 IlM and 2 III from extracted D A at a 
u itable concentrat ion ( 1 5  to 20 ng) .  Each react ion m ixture for eag A gene was 
amp l i fied a fol low (Table 2 .2 )  : denaturat ion at 95°C for 3 m i n  and then 50 cyc les 
of 94°e for I m in, 48°e for 45 , and noe for 45 s , A fina l  extens ion of DNA was 
o 
carried out for 1 0  m in at 72 e to en ure complete amp l i ficat ion. Sequenced sample 
from pos i t i  e amp l i fied pe R products served as pos it ive contro l  ( Fig. 2 .2 ) ,  where as, 
di t i l led water erved as a negat ive contro l dur i ng the ampl ificat ion.  The amp l ified 
D A product wa ana lyzed b e lectrophores is  us ing agarose prepared i n  TBE (Tris 
Borate -E DTA) buffer ( 1 .5 g/ 1 00 m l ) . The ge l s ize was 1 0  x 7 cm with a th ickness 
of 0 .3 cm .  amples '.: ere loaded on the ge l and a vol tage of 1 00v was appl ied . 
1 00bp D A ladder \i as used as marker to know the s ize of the peR product. The 
ample \i\ as a l lowed to run for 1 hr  and the gel was sta i ned with 0.5 mg Im l 
eth id ium brom ide for 30 m i n .  The band \ as seen by i l l u m i nat ion w ith U v  l ight i n  a 
ge l documentat ion system.  
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Fig. 2 .2 : Sequenc i ng chromatogram for pos i t ive contro l used i n  the amp l i ficat ion of Cag 
A gene.  
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2.5.  Detect ion of Delet ion i n  rdxA Gene of  H .pylori 
F r the detect ion of metr n idazole re i tant tra in , deletion in the rdyA were 
creened, where the nati e g ne y ie lded a 850-bp PCR product and its delet ion 
re u l ted in a 650-bp fragment. 
PCR wa performed i n  an automated thermal  c c ler ( PER K I  ELMER 2400), 
Ea h PCR was performed with a volume of 25 II I conta i n ing 1 x PCR master m ix, 
forw ard and rever e primer each at a concentration of I IlM and 2 III from 
approx imate I) 20 ng of template genom ic DNA. Each reaction m ixture for rdxA 
gel7e \\'a ampl i fied a fol lows (Ta ble 2 .2 )  : denaturat ion at 94°C for 5 m i n  and then 
35 cyc les of 94°C for 30 , 55°C for 30 s and noc for 30 s , A fina l  extens ion of 
o 
DNA was carried out for 1 0  m i n  at n C to ensure comp lete ampl ificat ion.  The s ize 
of the PCR product wa eval uated by e lec trophoresis on a 1 .5% agarose- Tris-
borate-EDTA ge l conta i n i ng 0.5 mg of eth id ium brom ide per m ! .  PC R amp l ification 
resul t  was compared to the pub l ic database. 
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2.6. Detect ion  of  Poi n t  M u tat ions  i n  the  23S rRNA Gene of H .pylori by 
eq uenc ing  
Point  mutation a t  t .. 0 p i t i  n i n  23 rRNA gene (2 1 42 and 2 1 43 )  were 
ident i fied b) ampl i fy ing 1 400 bp of the target gene encod ing 23 rRNA and then 
equence i t .  
PCR ampl i ficat ion were done b using o l igonuc leotide primers 1 8  and 2 1  
(Ta ble 2 . 1 )  complementar to con erved regions of the gene encod ing 23S rRNA . 
Each PCR wa performed with a volume of 50  f..l l conta i n i ng I x PC R master m ix, 
fon'v ard and re erse primer each at a concentrat ion of 1 f..lM and 2 f..l l from extracted 
D A .  Each react ion m i xture .. a ampl i fied as fol lows (Table  2 .2 )  : denaturat ion at 
94°C for 6 m i n  and then 40 cyc les of 94°C for 30 s, 50°C for 1 m in ,  and noc for 3 
o 
m in. A fina l  extension of D A was carr ied out for 1 0  m i n  at n C to ensure 
comp lete ampl ificat ion .  
PCR product " as purified \ i th Qiaqu i k  puri fication k i t  (Qiagen )  and a cycle 
equencing react ion was performed with the same pri mers. DNA sequenc ing was 
performed I n  Macrogen I nc ( Korea) under standard cond it ions. DNA sequence 
ed i t i ng and analysis .. ere performed by C lusta lX,  version 2 ( Lark in ,M .A et al. ,  
2007) softwear. 
2 .7. Phyl ogenet ic  A n a lysis of 23S rRNA 
2.7. 1 .  A n a lysis of the  n ucleotide seq u ence. The nuc leot ide sequence reported i n  th is  
study \ as analyzed by us ing the software Clu ta lX ,  version 2 ( Lark in ,M .A et  al., 
2007). Reference sequences used i n  the a l i gnment was obtai ned from N C B !  data 
base for a l l  23S rRNA from d i fferent Hel icobacter pylori Stra ins .  
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2.7.2.  uc Jeotide equence Acces ion u m be r . The part ia l  23S rRNA gene equences 
obtai ned in th i  tud) w re deposited i n  GenBank .  The accession number are 
h wn i n  Tabl 2 . 3 .  For compari n, pub l i  hed 23S rRNA gene sequences were 
down loaded from en Bank (Table 2 .3) .  
2 .7.3. Phyloge netic Tree. Tree iev" program wa used to draw the phy logenetic tree. 
Thi  program do e not create tho e trees, i t  s imply u es fi les created by c lusta lX to 
di p lay and pr int th tree . 
2 .8. Stat ist ica l A n a lysis 
oftware were used to ca lcu late Ch i-square which used to test for d i fferences 
proport ions bet\: een d i fferent group . P a lue less than 0.05 was reported as 
tat i st ica l ly s ign i ficant .  
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Ta ble 2 .3 :  equence acce ion number of the tra in  i nc l uded in the tudy 
train Sou rce G e n B a n k  acce ion 
no. 
23S rRNA ge ne 
Helicobacter pylori J99 Reference NC_00092 1 .  I 
stra in  
Heli oba fer pylori Reference NC_0009 l 5 . 1  
26695 stra i n  
Helicobacler pylori Reference NC_O I 1 3 33 . 1 
G_ � stra in 
Heli obacter pylori Reference NC_O I 0698.2 
Shi· rO stra i n  
Helicobacter pylori P 12  Reference NC_O I 1 498 . 1 
stra i n  
Helicobacter pylori Reference NC 008086. 1 
HPAGI stra i n  
Helicobacler pylori Reference NZ A B J PO I 000007. 1 
HPKX .J38. CA 4C1 stra i n  
Helicobacter pylori Reference NZ ABJOO I 0002 I 7. 1 
HPKX 438 AGOC1 stra i n  
Helicobacter pylori Reference NZ ABJPO I 003236 . 1 
HPKX .J38 CA .fC1 stra i n  
Helicobacler pylori Pat ient, FJ5275 1 6  
Hpllae- 1 UAE 
Helicobocter pylori Patient, FJ527508 
Hpllae-2 UAE 
Helicobocter pylori Patient, FJ52752 1 
Hpuoe-3 UAE 
Helicobacter pylori Pat ient, FJ 527524 
Hpuoe-.f UAE 
Helicobacter pylori Pat ient, FJ527509 
Hpuae-5 UAE 
Helicobacter pylori Patient, FJ5275 1 4  
Hpuae-6 UAE 
Helicobacler pylori Patient, FJ5275 1 1  
Hpuae- 7 UAE 
Helicobacler pylori Pat ient, FJ 527520 
Hpuae-8 UAE 
Helicobacter pylori Patient, FJ5275 1 3  
Hpuae-9 UAE 
Helicobacter pylori Pat ient, FJ527506 
Hpuae- 1 0  U A E  
Helicobacler pylori Pat ient, FJ5275 1 5  
Hpuae- 1 1  UAE 
Helicobacter pylori Patient, FJ5275 1 0  
Hpuae-12  UAE 
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tra in  Sou rce GenBank acce sion 
no. 
Helicobacter pylori Pat ient, FJ5275 1 2  
Hpllae- 13  UAE 
Helicobacter p) lori Pat ient, FJ527523 
Hpuae- l -l  UAE 
Helicoba ler pylori Pat ient, FJ5275 1 9  
Hpllae- 15  UAE 
Helicobacler p.vlori Pat ient, FJ5275 1 7  
Hpuae- 1 6  U A E  
Helicobocler pylori Pat ient, FJ 527505 
Hpllae- l - UAE 
Helicobacter pylori Pat ient, FJ 5275 1 8  
Hpllae- 18 UAE 
Helicobacler pylori Pat ient, FJ527522 
Hpllae- 1 9  UAE 
Helicobacler prIori Pat ient, FJ 527507 
Hpuae-20 UAE 
Con t i n u ed Ta ble 2 .3 :  equence accession numbers of the tra ins  i nc l uded in the tudy 
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CHAPTER I I I  
RESULTS AND 
DISCUSSIONS 
3. Re u Its and Discu ssion 
3.1 .  a m ple col lect ion 
Fr m Ju l  2008 to  Januar  2009, a tota l  of  90  Ga tric biop y ample 
\\  ere obta ined from dy pept ic pat ient referred for endo cop department in 
Zayed M i l itary Hospital (ZM H )  i n  Abu Dhabi,  AE. The mean age were 40 
y ear [ range 1 9- 80] ( Fig. 3 . 1 ) ;  64 male [7 1 . 1 %] ,  26 female [28 .9%] ) .  Wi th in  
the  pat ient popu lation 67 [74 .4%] were UAE nat iona ls  and the  re t are non 
local ( Fig. 3 .1 ) .  Pre ence of H. pylori are not I i nked to certa in age group 
and not concern for loca ls  only;  it is random ly d i  tr ibuted wi th in  groups. 
20 -
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Fig. 3 . 1 :  Mean age of pat ients and range of d i stribut ion. 
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Fig. 3 .2 :  Di fferent nat iona l i ty of  the pat ients. 
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3.2 .  Detect ion of  H. pylori i n  G astric Biop y Sa m ples. 
i net antra l  bi p y amples w re o l l ected from pat ient uffering from 
dy pept ic  y mptom . Primar creen ing \J a done u ing C LO test wh i le 
conformat ion wer done by P R meth d. The pre ent stud has ind icated that 
amono the 90 pat ient , 22 [24.4%] howed the pre ence of H. pylori by C LO test 
\ h i le 26 [ 28 .9%] b) PCR method with a band s ize of 298bp ( Fig. 3.3) .  As the 
primer deri ed from the DNA equence of a spec ie -spec i fic prote in ant igen has 
been how n to be present only in H. pylori th i s  what makes PC R techn ique more 
en i t i  e i n  detect ing H pylori compared to CLO te t and th i s  i s  why 7 samples 
v. here po i t ive by PCR and negat i e by C LO test (Table 3. 1 ) . These find ing 
corre late ery we l l  wi th  man other pub l i  hed resu lts regard i ng the h igh sens i t i v ity 
of PCR i n  comparing to other methods such as C LO test and Urea breath test 
(Murugesan et 01. , 2005) .  A l though our resu lts a l so shows that there are 7 other 
sample wh ich were posi t ive by C LO test and negat ive by PCR, which m ight 
contradict wi th our earl ier comment, we bel ieve that the absence of H. pylori in the 
7 samples could be due to the region from where the samples were col lected 
probabl) not i n fected with th i s  m icroorgan i  m, as it is known that th i s  m icrobe is  
present i n  patches i n  the e pat ients. At the same t ime, i t  shou ld be noted that  the 
amples analyzed by PCR and C LO test were col lected from the same regions and 
thus the absence of H. pylori in 7 out of 22 pat ients as analyzed by C LO test could 
be due to the poor sens i t iv ity of detect ion and not due to the region of sample 
col lect ion. 
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Fig. 3.3 : 1 .5 % Agarose gel e lectrophoresis of ampl i fied 298-bp PCR 
product from c loned target sequence of spec ies- spec ific  ant igen (SSA) 
gene (p26KDa); lane 1 sho\! s J OObp marker, Lane 1 6 : pos it ive control . 
l ane 1 5 : negat ive control, lanes 4, 5, 8, and 1 2  show posi t ive PCR assay 
performed on a gastric biopsy sample .  
Table 3. 1 :  PC R and C LO test resu lts 
C LO Test PC R Tota l 
positive negative 
pos itive 1 5  7 22 
no data 4 7 1 1  
negative 7 50 57 
Tota l 26 64 90 
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3.3. Detect ion of C) (otoxin As ociated Gene A ( Cag A )  
H pylori i n  fect ion i the major cau ati e agent of chron ic acti e ga tr i t is, 
\\ h ich p ia} a centra l  r Ie i n  the etio logy of pept ic u lcer d i  ea e and i a ri k 
factor II r devel pment f ga tric ancer. One of the most i ru lent factor that 
th ught to play a role in de e lopment of gastric cancer is  cytotoxin 
as" ocjal d gene A (Cog A) .  Cag A gene wa pre ent in  1 6  (6 1 .54%) of the 26 
ample that wa po i t i  e for H pylori by PCR ( Fig. 3.4) with a band s ize of 
1 28bp ( Fig. 3 .5) .  e eral tudie ha e shown that  the pre a lence of Cog A 
gene i n  H p.vlori i o lates range from 80% to 1 00% (Cover et a ! . ,  1 990; weel et 
a l . .  1 996; Uemura et a ! . . 200 1 ), \ here geograph ical d i fferences in the 
pre a lence ha e been found. as i t  has been reported i n  we tern countries that 
Cag A gene is present in  95% of H pylori i n fected pat ients. The same 
ob ervation \\ a pub l i  hed for ea tern countries, where Cag A gene expressi ng 
H pylori v" as found in 89 .3% of the 28 i so lates (Cover et a ! . ,  1 990; weel et a I . ,  
1 996; Uemura et  a I . ,  200 1 ) . A lthough our  pos it ive rate of Cog A gene (6 1 .5%) 
i s  10\\ er than pub l i shed reports from other nation (Cover et a I . ,  1 990; weel et 
a ! . .  1 996: Uemura et a ! . .  200 1 ), our resu l ts i s  acceptable as th i s  m ight be due to 
stra i n  ariat ion and geograph ica l  d i fferences a s  i t  was mentioned before. By 
comparing with data publ i  hed earl ier i n  the UAE, our fi nd ing i s  s im i lar to 
prev ious studies showing the presence of H pylori stra ins  in UAE with lower 






Fig. 3 .4 :  Percentage of Cag A pos i t ive and negat ive i n  the 26 H. pylori stra ins  
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Fig. 3 . 5 :  1 .5 % Agarose gel e lectrophoresis of amp l ified 1 28-bp PC R product 
from c loned target sequence of Cag A gene; lane 1 shows 1 00bp marker Lane 1 4 : 
posi t i ve control : lane 1 5 : negat i ve control ,  lanes 2, 3, 4, 6, 7, 8, 1 0, 1 L 1 2  and 1 3  
sho\\ posit i ve PCR assay performed on a ga tric b iopsy sample .  
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3.4. Detect ion of Delet ion i n  rdxA Gene of  H .pylori 
I n  re ent year , nitA gene analy i of the fre h ample howed that the 
metron idaz Ie re i tance j main l  attr ibuted to  the  mutat ion i n  th is  gene inc l ud i ng 
gene del t ion ( Debet -0 enkopp et a I . ,  1 999). In th i  tudy on ly 3 ( 1 1 .5% of tota l )  
tra i n  out o f  2 6  \ ere found t o  carr a 200 bp deletion i n  the rdtA gene. A l l  three 
sample "' ere negat i e for ident ificat ion b LO te t (Ta ble 3 .2 )  and a l so are 
characterized b the ab nee of Cag A gene (Table 3.3) .  This  absence of functional 
rdxA encod ing for n i troreductase causes no surv iva l  d i sadvantage to 
m icroorgan i  m i n  the absence of this ant ib iotic (Goodwin et at., 1 998) .  So, 
res i  tant mutants may pers i t for decades, often co-existence w i th sLlscept ible 
organ i sm and th i s  i s  what we found i n  some of the samples where two band sizes 
expres ed in the same stra i n  ( Fig 3.6 D) .  There i a trong assoc iation between the 
presence of eag A gene and the deletion in the rdxA gene (p = 0.02) .  Re lat ion 
bet\\ een Cag A and rd'CA 200bp delet ion are not c lear. Further researches w ith more 
sample are needed to confinn these resu l ts .  
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Table 3 .2 :  C LO te t re u l t  and it re lation to metron idazole u cept ible and 
re i tant tra in  
rdxA gene C LO Test Tota l 
positive no data negative 
Resista nt 0 0 3 3 
Suscepti ble 1 6  2 5 23 
Tota l 1 6  2 8 26 
Ta ble 3.3: Presence of eag A gene among metron idazole (rd-cA) suscept ib le and 
res i stant stra ins 
rdxA gene Cag A gene Tota l 
pos itive negative 
Res ista nt 0 3 3 
Susceptible 1 6  7 23  
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Fig. 3.6:  1 . 5 % Agarose ge l e lectrophoresis of amp l i fied pe R product from 
c loned target sequence of rd'(A gene; (A)  and ( B )  shows suscept ib le  stra ins (S )  
for metron idazole wi th a band s ize of  850bp, W h i le (C)  and ( D) Shows 
res istant stra ins (R )  w ith a band ize of 650bp and suscept ib le one (850bp), 
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3.5. Detect ion of Poi n t  M u tat ions i n  the  23S rRNA Gene of  H .pylori by 
eq uenc ing  
The prevalence of  c larithr myc l l1 re i tance ane from 1 % i n  on ay to 
65 .5% i n  n i ted rab Em i rate as I -Fare i reported (2007). Recent data from 
We tern Europe i nd icate that greater than 60% of fa i led c larithromyc in  based 
treatment are as oc iated \ i th c Jarithromyc i n  re istant H. pylori i solates ( B laser, 
1 997; over el aI. , 1 990; Van Doorn et aI. , 1 998, Arents ef al. , 200 I ;  
M ukhopadhyay ef aI. . 2000) .  
The present study d id not e 'am i ne cu ltured isolates of H. pylori from biops ies. 
Rather i t  exam i ned the biopsies d i rect ly  us ing molecular techn iques Depend ing on 
the publ i shed data, c larithromyc i n  b i nd i ng s ite located in the V doma in  of 
pept id) l tran ferase-encod i ng region of the 23S rRNA gene (Uemura ef al. , 200 1 ). 
( Fig  3 .7) .  M utat ions at th i s  s i te a lter the mechan ism of b ind ing making the bacteria 
res istant to the ant ib iot ic .  Three point  m utat ions in two posi t ions of the b inding s ite 
have been de cr ibed in wh ich an aden ine res idue is rep laced by guan i ne or a 
cytoc ine residue at adjacent pos i t ions :  A2 1 42C. A2 1 42G and A2 1 43G . 
. -
fI "· ,. 
- tij 
• 
Clarithromycin bi ndi ng site 
Fig. 3 .7 :  C larithromyc in  bind ing s i te .  
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I I  0 ample w ere pos i t ive b the P R as ay for the amp l i fication of the 
1 400bp of _3S rRj A gene ( Fig. 3.8) .  equenc ing analy i ho\ ed that 9 out of 26 
(34 .6%) tra in  \\ ere mutated ( uscept ib le tra in  ho\! ed i n  Fig. 3.9) .  I n  th i  group 
2 tra i n  [ 22 .22%] had the 2 1 42G ( Fig. 3. 1 0 ), 5 tra i n  [ 5 5 .56%] A2 J 43G ( Fig. 
3. 1 1 ), I tra i n  [ 1 1 . 1 1 %] 2 1 43C and 1 tra in  [ 1 1 . 1 1 %] .. i th h ighly changed i n  
equence ( Fig. 3. 1 2 ) .  The pre a lence of  the poi nt m utat ion A2 1 42/43G among our 
pat ient i h igher than what other countries reported (29% in Japan ( Kato et af., 
2002)) .  and st i l l  lower than 65%, what A I -Faresi reported (2007). I n  add i t ion there 
\\ a no re lat ion bet\ een the presence of Cag A gene and the c lari thromyc in  
re i tance ( P  = 0 .07) (Table  3.4 ) .  
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Ta ble 3 .4 :  Pre ence of 'ag A gene among lari thromy in (23 rRNA ) su cept ib le 
and re i tant tra i  n 
23S rRNA gene Cag A gene Tota l 
pos itive negative 
Res ista nt 8 1 9 
Suscept ib le 8 9 1 7  
Tota l 1 6  1 0  26 
Fig. 3.8: l .5 % Agarose gel e lectrophores is  of amp l ified 1 400bp PCR 
product from c loned target sequence of 23S rRNA gene; lane I shows 
1 00bp marker, l ane 5 :  negat i  e contro l ,  l anes 1 ,  2, 3 and 4 show pos i t i ve 
PC R assay performed on a gastric b iopsy sample .  
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hil) 
uscept ib le stra in  
Fig .  3 .9 :  equenc ing chromatogram for c larithromyc in  suscept ib le stra in  
i so lated from UAE pat ients 
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· \- G 
Re i stant stra in  at 2 1 42 
\ 
I 
tJ l �I 
Fig. 3 . 1 0 : Sequenc i ng chromatograms for c larithromyc i n  resistant 
stra i n  with nuc leotide a lterat ions from A to G at 2 1 42 posi t ion isolated 
from U A E  pat ient .  
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Resi tant stra i n  at 2 1 43 
! 
I �, ( I I � I 
I f '  I 
I I I I 
II 
Fig. 3 . 1 1 :  Sequenc ing chromatograms for c larithromyc in res istant stra in wi th 
nuc leotide alterat ions from A to G at  2 1 43 posi t ion . 
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F ig. 3 . 1 2 :  Sequenc ing chromatogram for h igh ly changed sequence at the 
c l ar ithromyc in  b ind ing s i te (2 1 42 and 2 1 43) .  
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3.6. Phylogenet ic  Ana lysis of  23S rRNA 
H. pylori tra i n  from E were studied to gam new in ight i nto the 
populat i  n genet i structure of the pathogen and to study the impl ication of 
genot) pe in di ea e .  A lthough H. PJJlori i n fect ion occur worldwide, there are 
ign ificant d i fference in i ts prevalence wi th in  and between countries. 
D equence ph logenet ic  anal  i of the 23S rRNA m iddle region of the 
gene ind icate that the stra i n  from UAE harbor a un ique 23S rRNA sequences 
(TIGGTTATATTCCA) that is common am ng i solates from the UAE pat ients and 
d i fferent from other tra ins ( Fig 3. 1 3) .  The 23S rRNA gene sequence data are 
ign i ficant l)  more re l iable than l 6S rR A gene sequence data for ident ificat ion, 
c l assificat ion. and phylogenet ic  anal sis of he l i cobacters pr imari ly because of the 
threefold-h igher number of i n format ive bases ( Dewh i rst el al., 2005 ;  M ikkonen et 
al. ,  2004 ; H ann inen el al . . 2003 ; Vandamme et al. ,2000). 
Genom ic Compar ison between H. pylori stra ins were done by software 
C lusta lX.  vers ion 2 .  Reference sequences used i n  the a l ignment was obtained from 
C B I  data base for a l l  23s rR A from d i fferent Helicobacter pylori Stra ins .  The H. 
pylori J99 (GenBank accession no. C _ 00092 1 . 1 ), H. pylori 26695 (GenBank 
accession no. C_0009 1 5 . l ), H. pylori G27 (GenB ank accession no. NC_O l 1 333 . 1 ), 
H. pylori P l 2  (GenBank  accession no. C_O I 1 498 . 1 ), H. pylori Sh i470 (GenBank 
accession no. C_O I 0698.2), H. pylori H PAG l (GenBank accession no. 
NC_008086 . 1 )  and H. pylori HPKX_438 genomes were down loaded. Homology 
searches were conducted agai nst the genomes sequences of H. pylori on the 
nuc leot ide leve l by us ing the BLA T software package. The BLAST output was 
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proce ed further to determ ine ) nten ic region bet\', een two genome ( Fig 3 . 1 4, 
3. 1 5  and 3. 1 6) .  
o 3 0  4 0  
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Fig. 3. 1 3 :  H pylori sequences from d i fferent stra ins  i solated from UAE pat ients' shows 
the un ique po i t ion (TTGGTTATATTCCA) for th i s  stra ins  wh ich d i fferent iate them 
from other H pylori stra ins .  
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Helicobacter pylori J99 
l dent i t ie = 669/67 1 (99%), Gap = 1 /67 1 (0%) 
I I  pylon Iiplloe-5 1 
1Ip'1 Ion J99 1 059039 
Ii p;.lon liplloe-5 60 
Ii PI I'm J99 1 058979 
II. pylon lipuae-5 1 20 
lipllon J9Q 1 05 9 1 9  
H pylon Hpuae-5 1 0 
Hpl fon J99 1 058 59 
II pyfon Hp/lae-5 240 
H ,,"OrT J99 1 05 799 
II. pylon Hpllae-5 300 
Jl pl fon J99 1 058739 
H p;. fon Hplloe-5 360 
IIpl/on JQ9 1 058679 
H p;.lon Hplloe-5 420 
/I p) lort JQ9 1 0586 1 9  
II. p;.lon Hpllae-5 480 
H p'llon JCJ9 1 05 559 
H p) Ion Hpllae-5 540 
H p} fan J99 1 058499 
H p;.lan Hpuoe-5 600 
H pIlon J99 1 058439 
II. Jl) fan Hplloe-5 660 
II pI lon J99 1 05 379 
TGGTT-ATATTCCAATACCGACTATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGAG 




































Fig. 3 . 1 4 : A l ignment of the DNA sequences of part ia l  23S rRNA gene (670bp). Reference 
stra i n  is H Pylori J99 ( Red Color) and i solated stra i n  from UAE patient is H. pylori 
Hpuae-5 . Differences i n  sequences are shown w i th red color. Gaps i n  the D A sequence 
are marked wi th  dashes, and ident ica l  nuc leot ides are ind icated by dots. 
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Helicobacter pylori 26695 
l dent i t ie = 668/67 1 (99%), Gap = 1 /67 1 (0%) 
/ I  pylon Iipuoe-5 I 
/I plion :66<)5 44074� 
H p) /Ort HpuDe-5 60 
H [1}lon 26695 446 O� 
H p)lon HpuDe-5 1 20 
/I j1l/l)n 26695 446 6� 
H p)1an Hpuoe-5 I 0 
H f1l lon :6695 446922 
II. p)10n /lpl/oe-5 240 
H f1l lort 20095 4469 2 
II. pylon HpuDe-5 300 
H p; lort 26695 447042 
H p;'lon HpuDe-5 360 
II [1} lol/ :M95 447 1 0� 
H p)lon Hp1/De-5 420 
II rolort 2fJ()95 44 7 1 62 
H p)10n HpuDe-5 480 
If p) lori 26695 447�22 
H p)lon IIp1/De-5 540 
II p:, lon :61\9: 447282 
H p) lon HpuDe-5 600 
/I p) Ion 26695 447342 
H. p)lon HpuDe-5 660 
/I p;lan 76695 47402 
TGGTT-ATATTCCAATACCGACTATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGAG 













4474 1 2  
59 
44680 1 









447 1 0 1  
4 1 9  
447 1 6 1  
479 




4473 4 1  
659 
447401 
Fig. 3 . 1 5 : A l ignment of the D A sequences of part ia l 23S rRNA gene (670bp)o Reference 
stra i n  is H Pylori 26695 ( Red Color) and i solated stra in  from UAE pat ient is H pylori 
Hpuae-5 .  Differences i n  seq uences are shown with red color. Gaps i n  the DNA sequence 
are marked wi th dashes, and ident ical nuc leot ides are ind icated by dots. 
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Helicobacter pylori HPKX_ 438_A GOC1 NZ_A BJO 01 00021 7 
I I  P' Ion I I puae-5 
II P' Ion I I I'''\: 
I I  p ion Hpuae-5 
I I  P' Ion I I I''' '\ 
H p� Ion Hpuae-5 
II p\ Ion I I I''' 
H p� Ion Hpuae-5 
II p) 'oP HI''' 
H p) Ion Hpuae-5 
II P\ lor III''''' 
H p\lon Hpuae-5 
II ,,, INI HI''' 
H P) Ion Hpuae-5 
11 P\ l("In III'K" 
H P) Ion Hpuae-5 
I P\ lor HI''' '\ 
H p)lon Hpuae-5 
II p\ Ion 111''''\ 
H p)lon Hpuae- -
II p\ lor HI''''' 
H p�lon Hpuae-5 
H p) Ion HI''''' 
H p)lon Hpuae-5 














1 3  
375 
1 50 1  
435 
1 44 1  
495 
1 38 1  
555 
1 32 1  
6 1 5  
1 26 1  
TGGTT-ATATTCCAATACCGACTATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGAG 















3 1 4  
















6 1 4  
1 262 
Fig. 3 . 1 6 : A l ignment of the DNA sequences of part ia l  23S rRNA gene (670bp) .  
Reference stra i n  i s  H. pylori HPKJC 438_A GOCI ( Red Color) and i solated stra i n  
from UAE patient i s  H. pylori Hpuae-5 . Differences i n  sequences are shown w ith 
red color.  Gaps i n  the D A sequence are marked with dashes, and identical 
nuc leot ides are ind icated by dots. 
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The 23, rRNA equence for the t\\ ent) tra in  l i sted i n  Fig 3. 1 7  wa 
d t rm ined b u ing  equenc i ng methods. equence were entered i n  23S 
rRXA databa e and al igned ba ed on econdary structure. Phylogenet ic trees 
\\ ere constructed u ing  the neighbor-jo in  i ng  method. The neighbor-jo in i ng 
tree con tru ted from the part ia l  23 rRNA gene sequences i s  hown i n  Fig. 
3. 1 8  and Fig. 3. 1 9 . The more deta i led i m i lar ity analysis of the pal1 ia l  23S 
rRNA gene equence among Helicoba fer py lori stra ins is shown in Tab le 3.5 
and 3.6.  The i m i lari t ie of the 23S rRNA sequences of H pylori stra i ns 
i olated from UAE pat ient to those other publ i shed sequences were 99% 
ex ept for H pylori HPKX_-13 _CA .fCl tra i n  ( Z_ABJ PO I 003236. 1 )  (Ta ble 
3 .5) .  
Two main  stra i ns are found i n  UAE pat ients, one i s  c lose ly related to 
Helicobacter pylori G2 7 and the other one to Helicobacter pylori J99 j ust the 
d i fference in two or three nuc leot ides ( Fig. 3 . 1 7 ) .  H pylori Hpuae-5 ( Fig. 
3.20) i s  an examp le of one group of tra i ns which is  c losely  re lated to H 
pylori J99, \\ here i t  has two nuc ieotides d i fference ( Fig. 3 . 1 4) ;  A lso it i s  
s im i lar to  H pylori 26695 wi th  th ree n uc leot ides d i fference ( Fig 3. 1 5) .  H. 
pylori HPKX_.f3 _AGOCl stra i n  i s  exc l uded from th i s  study because of 
m i ss ing nuc leotides ( Fig 3 . 1 6) On the other hand H pylori Hpllae-20 ( Fig. 
3.2 1 )  i s  an example of second group wh ich i s  c lose ly re lated to H. pylori G2 7 
but d i fferent  i n  two n uc leot ides. A l l  isolated stra ins  sequences showed i n  
APPEND I X  2 .  
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CLUSTAL 2 . 0 . 1 0  mu l t �p l e  se quence a l i gnment 
H . Py rl 
H . y L rl 
H Py r ... 
H .  FyI r ... 
H . PylorI 
H . :yl rI 
H .  Py C 1  
Hpu a e - l  
Hpu a e - 2  
Hpuae 3 
Hpuae - 4  
Hpu a e - 5  
Hpuae - 6  
Hpuae - 7  
Hpu a e - 8  
Hpuae - 9  
Hpuae - 1 O  
Hpuae - l l  
Hpu a e - 1 2  
Hpu ae - 1 3  
Hp u ae - 1 4 
Hpuae - 1 5  
Hpuae - 1 6  
Hpua e - 1 7 
Hpuae - 1 8  










TGGTT TATTr TACCGAC'T -GTGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGT���ATTC TACCGAC� -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGT ,��A:-1C TA CGA('� -ATt;I,AGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGT �AAT '  TTC TACCGA(,TCATGI3AGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTAA�ATTCCAATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTT :'A� TCCAATACCGACT -ATr;I;AGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
l GGTTAATAI'TCCAATACCGACT -ATGGAGCGTGATGG(,GGGACSCATAGGGTTAAI,rrA 
TGGTTA-TATTCC-ATACCGACT-ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 






TGGTTA-TATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA- -ATTCC-ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA- -ATTCC -ATACCGACTTATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA- -ATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA -TATTCTG-TACCGACT -ATGGAGCGTGGAGGGGGGACGCGTAGGGTTAAGCGA 
TGGTTA -TATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCCAATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC -ATACCGACT TATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
T GGTTA-TATTCC -ATACCGACT TATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
* * * * * * * *  * * * * * * * * *  * * * * * * * � * *  * * * * + * * * * * * * *  
Fig. 3 . 1 7 : A l ignment o f  the 0 A sequences of part ia l 23S rRNA gene (670bp). Reference 
stra ins  used in the a l ignment are in Red Color (H Pylori 26695, H Pylori HPAG1,  H 
Pylori G2 �. H Pylori Shi..f 70, H Pylori P12, H Pylori J99, H Pylori HPKX), wh i le the 
sequences of stra ins  i solated from DAE pat ient are in  b lack color with H pylori Hpuae 
name. The d i fferences i n  sequences are shown with d i fferent colors with boldface. Gaps 
i n  the 0 A sequence are marked with dashes, and identical nuc leot ides are i nd icated by 
stars . See Appendix  1 .  
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r---- Hpuae-3 
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Hpuae- 14  
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Hpuae-4 
f-- Hpuae- 1 9  
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r------ Hpuae- 16  
L-_________________________ Hpuae-1 2 
00' 
Fig. 3 . 1 8 : e ighbor-jo in ing tree based on part ia l  670-bp 23S rRNA gene sequences. The 
tree w as rooted w ith H. pylori J99. The number at each branch  point  represents the 
percentage of bootstrap support ca lcu lated from 1 ,000 trees .  The scale bar represents the 
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Fig. 3 . 1 9 : e ighbor-jo in ing tree based on part ia l  670-bp 23S rRNA gene sequences. The 
tree was rooted with H pylori G27. The number at each branch point  represents the 
percentage of bootstrap support ca lcu lated from 1 ,000 trees. The scale bar represents the 
sequence d ivergence. 
- 66 -
Table 3 .5 :  i m i larit) f the part ia l  23S rRNA gene equence i a lated from H. 
p.vlori Hpllae-5 among other Heli obaete,. p lori stra in . 
Acce ion 
00092 1 . 1  
l A BJ P0 1 000007. 1 
Z BJ00 1 0002 1 7. 1  
De c ri ption Max ident 
Hel icobacter p )  lori J99 
I -lc l icobactcr p) lori 26695 99% 
Hel ie baeler pylori I I PK X_ 43 8_CA4 1 99% 
Hel icobacter pylori I I P KX_ 43 8_AGOC I 99% 
I A BJ PO l 003236. 1 l Iel icobaeter p) lori H P K X_ ·B 8_CA4C I 89% 
Table 3 .6 :  i m i lar i ty of the part ia l  23S rRNA gene sequence i a lated from H 
pylori Hpuae-20 among Helicobacter pylori stra ins 
Accession Desc ript ion M a x ide n t  
C 0 1 1 3 33. 1 Hel icobacter py l ori G27 99% 
C 0 1 1 498. 1 H e l icobacter p) l ori P I 2  99% 
C 0 1 0698.2 Hel icobacter pylori hi470 99% 
NC 008086. 1 Hel icobactcr pylori H PAG I 99% 
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CHAPTER I V  
CONCULSIONS 
4. Conc l u sions 
e eral conc lus ions cou ld be dravv n from the presented tud are as fol low: 
(i) The re lation h i p  between deletion of 200bp in rdxA gene (gene which is  
re pon ib le  fi r h ighly re i tance for metron idazole) and Cag A gene needs 
further re earche at the molecu lar field with h igh number of ample to 
make the re lation more c lear. 
( i i )  The find ing o f  a h igh rate o f  res i stance to c \arithromyc in ,  which i s  most 
l i ke ly due to the vast con umpt ion of erythromyc in  in cases of upper 
respiratOr) i n fect ions, ca l l s  for an effect ive erad i cation program and 
d isqua l ifies c lar ithromyc i n  as an effect ive regimen.  These resu l ts further 
confi rm the essence of cont i nuous monitori ng of anti biotic res istance 
patterns in order to reduce the rate of erad icat ion fa i l ure in UAE or any 
other target popu lat ion. These data may provide the basi s  for treatment 
recommendations for H pylori erad ication in UAE.  
From th is  stud : fuJ I  genom ic sequenc ing for the  new H pylori stra i ns wh ich  have been 
found i n  the U A E  pat ients ( loca l s  and non loca ls)  w ith un ique sequences in the 23S rRNA , 
i s  recommended. 
A lso I h igh l y  recommend us ing peR techn ique in a l l  c l i n ica l  laboratories and hospitals i n  
UAE for detect ing H pylori, and th is  i s  due  to  the sens i t iv ity of  pe R more than other 
methods in the i dent i fication of th i s  bacteria, beside the abi l i ty of the peR assay which 
has the advantage of detect ing low numbers of bacteria after successfu l  or unsuccessfu l  
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APPENDIX I 
A P P E N D I X  I 
CLUSTAL 2 . 0 . 1 0  mul t �p l e  sequence a l ig nment 
H .  Py 
11 yi r 
H. Pyi 
H .  Py 
H .  Py 
H . Py 
H Pyi rI 
Hpu a e - I  
Hpuae-2 
Hpu a e - 3  
Hpua e - 4  
Hpuae 5 
Hpuae - 6  
Hpuae - 7 
Hpu a e - 8  
Hpu a e - 9  
Hp uae - l O  
Hpua e - l l  
Hpuae - 1 2  
Hp uae - 1 3  
Hpu a e - 1 4 
Hpua e - 1 5  
Hpuae - 1 6 
Hpua e - l ­
Hpu ae - 1 8  
Hpua e - 1 9 
Hpuae -20 
H. Pyl r� 
H .  Pyl r� 
H .  Pyl r �  
H .  PY.Lori 
H. Pyl ori 
H.  Py.1 r� 
H . Py.1 r� 
Hpuae - l  
Hp u a e - 2  
Hpu a e - 3  
Hpu ae - 4  
Hpu a e - 5  
Hpuae - 6  
Hpu a e - 7  
Hp u a e - 8  
Hp uae - 9  
Hpua e - l O  
Hp uae - l l  
Hpu ae - 1 2  
Hpua e - 1 3  
Hpuae - 1 4  
Hpu a e - 1 5  
Hp uae - 1 6  
Hpua e - 1 7 
Hpuae - 1 8  
Hpu a e - 1 9 
Hpu a e - 2 0  
L 6  9 
HPAGI 
G.::.. 7 














� ,GTT 7ATT ; TACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA- TATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA -TATCC - -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA -TATTCCAATACCGACT - GTGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-T-TTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA- TATTCCAATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC -ATACCGACT-ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC-ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC -ATACCGACT-ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA- -ATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA- -ATTCC-ATACCGACTTATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCC -ATACCGACT-ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA- -ATTCC -ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCTG-TACCGACT-ATGGAGCGTGGAGGGGGGACGCGTAGGGTTAAGCGA 
TGGTTA -TATTCC-ATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA-TATTCCAATACCGACT -ATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA- TATTCC -ATACCGACT TATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
TGGTTA- TATTCC -ATACCGACTTATGGAGCGTGATGGGGGGACGCATAGGGTTAAGCGA 
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fl .  rl ;;;69 
H . Fyi r I HPA'":l 
H .  P}' rl , 
H. Pyl r ,'h I 4 70 
H .  P}'I rl Fl2 
H .  FyI rl 199 
H. Py r.l flPKX 
Hpuae 1 
Hpu a e -2 
Hpu a e - 3  
Hpuae 4 
Hpuae 5 
Hpu a e - 6  
Hpuae - 7  
Hpu a e - 8  
Hpu a e - 9  
Hpuae - l O  
Hpu ae - l l 
Hpu a e - 1 2  
Hpuae - 1 3  
Hpuae - 1 4 
Hp uae - 1 5  
Hpu ae - 1 6 
Hpu a e - 1 7 
Hpuae - 1 8  
Hpua e - 1 9  
Hpuae -20 
fl .  Pyl 'rl 
H. Pyl o r I  
H. Pyl o r I  
H. Pyl C'r.l 
H. Pyl C' r .l 
Ii .  PylorI 
H.  Pyl orI 
Hp u a e - l  
Hpuae -2 
Hpuae - 3  
Hpu ae - 4  
Hpu a e - 5  
Huaep - 6  
Hpua e - '"  
Hpu a e - 8  
Hpua e - 9  
Hpua e - 1 O  
Hpuae - l l  
Hpua e - 1 2  
Hpua e - 1 3  
Hpuae - 1 4 
Hpuae - 1 5  
Hpuae - 1 6  
Hp ua e - 1 7 
Hpu ae - 1 8  
Hp u a e - 1 9  








r,TATTTGAAACCCAAACAGGCTrTTTGAGTCCT7TTAGGAC -AAAG� ;AGAATCGCTGAT 
GTATTTGAAACCCAAACAGGr.T�TTTGAGTCCTTTTAGGAC -AAGA��;GAATCGCTGAT 
,TATTTGAAACCCAAACAGGCTCTTTGAGTCCTTT TAGGAC - AAAG '�AGAATCGCTGAT 
GTATTTGAAACCCAAACAGGCTCTTTGAGTCCTTTCAGGAC -AAAG��AGAATCGCTGAT 















GTATTTGAAACCCAAACAGGCTCTTTGAGT CCTTTTAGGAC -AAAGGGAGAATCGCTGAT 
GTATTTGAAACCCAAACAGGCTCTTTGAGTCCTTTTAGGAC -AAAGGGAGAATCGCTGAT 
GTATTTGAAACCCAAACAGGCTCTTTGAGTCCTTT TAGGAC -AAAGGGAGAATCGCTGAT 
GTATTTGAAACCCAAACAGGCTCTTTGAGTCCTTT TAGGAC -AAAGGGAGAATCGCTGAT 
GTATTTGAAACCCAAACAGGCTTTTTGAGTCCTTT TAGGAC -AAAGGGAGAATCGCTGAT 
GTATTTGAAACCCAAACAGGCTCTTTGAGTCCTTTTAGGAC -AAAGGGAGAATCGCTGAT 
GTATTTGAAACCCAAACAGGCTCTTTGAGTCCTTTTAGGAC -AAAGGGAGAATCGCTGAT 
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H '" f, ') 
H HPA ;1 
P .  
H .  51] 4 7  
fl .  I PI . 
H .  9'1 
Hpuae 
Hp uae-2 
Hpu a e - 3  
Hpu a e - 4  
Hpu a e - 5  
Hpuae 6 
Hpuae - 7  
Hpu a e - 8  
Hpu a e - 9  
Hp uae - 1 0  
Hpuae - 1 1  
Hpu a e - 1 2  
Hpuae 1 3  
Hpuae -1 4 
Hpuae - 1 5  
Hpuae - 1 6 
Hpuae - 1 7 
Hp uae - 1 8  
Hpua<2 - 1 9  
Hpu a e -20 
HfKX 
H . Pylon b695 
H .  Pyl o n  I1PAG1 
H . Pyl c n  G2 7 
H . Pylo r I  Sh i 4 70 
H .  FylC'u P1 2 
H . Pyl C' r I  1�Q 
.11 . Pyl (;>r � HPKX 
Hpu a e - 1  
Hpu a e - 2  
Hpu a e - 3  
Hpuae - 4  
Hpu a e - 5  
Hpua<2 - 6  
Hpuae - 7  
Hp ua e - 8  
Hpua e - 9  
Hpua e - 1 0  
Hpu a e - 1 1  
Hpu ae - 1 2  
Hpuae - 1 3  
Hp uae - 1 4 
Hpuae - 1 5  
Hpuae - 1 6 
Hpuae - 1 7  
Hpua e - 1 8  




CAl, TAGATGA�ATGAGTATT�TAAGGCGCGTGAAAGAASTCTGGTTAAGGAACT�T ,rA 
CAGGTAGATGAGATGAGTArTCTAAGGCGCGTGAAAGAAr.TCTGGTTAAGGAACTCTGCA 
CAG ,TAGATr�SATr,AGTATTCTAAGGCGCGTGAAAGAAr.TCTGGTTAAGG�ArTCTGCA 
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Py rl 2 6q<; 
Fy I I  HFA ;1 
H. Pyl II G, 7 
Ii . Pyl rr -I] <1 
Ii . Pyl "1 P12 
F . Pyl I I  J9 q 
F. Py II HFKX 
Hpu a e - l  
Hpu a e -2 
Hpu a e - 3  
Hp ua e - <1  
Hp ua e - 5  
Hp uae 6 
Hpuae - 7  
Hpu a e - B  
Hpu a e - 9  
Hpu ae - l O  
Hpua e - l l  
Hpua e - 1 2  
Hpuae - 1 3  
Hpuae - 1 4 
Hpu a e - 1 5  
Hpu ae - 1 6 
Hpu a e - 1 7 
Hp uae - l B  
Hp uae - 1 9  
Hpuae -20 
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A l ignment o f  the 0 A equences o f  part ia l  23S rRNA gene (670bp). Reference stra ins 
u ed i n  the a l ignment are i n  Red Color (H. Pylori 26695, H. Pylori HPA G 1 ,  H. Pylori 
G� �. H Pylori Shi.j 70, H Pylori P 12, H. Pylori J99, H. Pylori HPKX), whi le  the 
equences of stra i n  i olated from UAE pat ient are i n  b lack color wi th H pylori Hpuae 
name. The d i fference in sequences are shown with d i fferent colors with boldface. Gaps 
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F ig. l :  Sequenc i ng chromatogram of the 23S rRNA gene i solated 
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Fig.  2 :  equenc ing chromatogram o f  the 23S rRNA gene i solated 
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Fig .  3 :  Sequenc i ng  chromatogram of the 23S rRNA gene isolated 




G ' T.,. . J �I� 
]3C 1.JO 
rc r::; � �T"'G 
.1  
TKJ ; --..,.. 
.JC !r 
I'G ;� 'G': � "G 'GG :'j': ' 
11] 100 
bO 
1/ '7 'IJGI� '" 




G f. ;':CT 
�c ,.. J' 
' . J 




G�"·]�'"�G''' " �G 
I [ 
\,I �\ I, � A.,{', { ;I � I'f n  '',',In, l ' �- J'-"w,r; 1 v ,. '-. rl 'A1<OIl" CV>6-f." ·' ·J ' '''1 ·l L1 1';:.f',),:' r� .1d� .ft 1  r� 
5(1 :60 270 
Glr,·G ,TG · 3 TG .GT 
33,) 390 
� 'G .�TGTT ;" I'r • 
51(1 G: ' �G GT 
h",' .I�'J 




.3 .' ,':fcT( G' T _ /]'J 
100 411 � 43� 
310 
1'''TGC 
:;.: T'T fG' "T �G·"Iw"G IGG --13" �� �, .G G'; ':rr::; 
53'; 








J r ,(]"'TCG:G 
;.1') 
GGTG�G'" 
i40 �5{' .;€� 4'iC 
�':CTG:1 CG8T ';�TC:; �]GTT /_ G." ::;G 'IGC � 










\ � ,� 
�� �DO 
:t�!J7 �G -,J �G 
6::-C 
"G ��("T' i� ," J 'J TGG:; :;C-�'G 'f',.-.. "l1"I ( ,f} � GTG 
,� t; .' • 
- I' \ _  , ', It''1! ,V; i( Vl'!�,� ,Vi I .  1" 1/\ " UJJ�l.U _ Uw (I ( \ f { \ n,.lr.LJ�'(�...J 
� 
� 
� ... .. .  
� :: I:l � � 
=='" --' 
'----" .. =::::r= .... 
-;, C . 
[---. 
"'----1: :  
























F- • r:: >-:l C'_'::> 
� 
-� 







Fig .  4 :  Sequenc i ng chromatogram of the 23S rRNA gene i solated 
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F ig. 6 :  Sequenc ing chromatogram of the 23S rRNA gene isolated 
form H pylori Hpuae-6 
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Fig .  7 :  Sequenc ing chromatogram of the 23S rRNA gene i solated 
form H pylori Hpuae- 7 
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Fig .  8 :  Sequenc ing chromatogram of the 23S rRNA gene isolated 
fonn H. pylori Hpuae-8 
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Fig .  9 :  Sequenc i ng chromatogram of the 23S rRNA gene i so lated 
form H. pylori Hpuae-9 
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Fig .  1 0 : equenc ing chromatogram of the 23S rRNA gene isolated 
form H. pylori Hpuae - l  0 
- 1 1 1  -
tv I I  
10 �v 
:G,fG G GG' r:uJ I T  � [ 1  1\ 
I . 
�I 
\\ (, .r. I, , . � r r it , 1  A I, c i, 'rl\ " � ., 'I I,,,, ' I . ,� 1 , I )  . I � {1 1 . t, . ,V I II � I I\ A '  ,I � - 1.';-'!I \:� i j({ \; V l \1 V .. fitV IJ 1\ �/ldYJJJ��Lj�V 'J U\ � 11 J�'I II 
:)� }41) 15:) iSD jiG If;11 120 2CIJ 210 
100 .1. �J 
G" /J l [G I� _I: ; I� j 
I� . ' r  I I  � I l . 1\ /. t 1 ,'1 t I £ ', I I I " " ! "' / l l , j I J  , � ! I, , � .,' j . , vV ; ,� -!. ,1 · . :""- .1.. ... � "'.. r: '  
2� :m 24a 
. T '1G � j ' G  , ,,'!"" . �_  <,J}.: Tr-, �rrJ " Gr:f"" "I� T T .GG. ,C L __ GGG G � rr�G("T'J r!-(r;G��(jo;'GC'" IJ ' ' J  -;«( leT .· :7C� r" T;:� � G T: J'"'C' .. G" I�CI.?C �.'\,. ,,'", '.J 
I , t , , :, ," � � [ ( N d V '  ,1 ' 1\' 1 J \� i' l � [i'. / ' \,f l l ' I /� I '1' u \ ,{1/: r l) L ' ( ,/' UJ "/' Y -1) � , 
'{ �) Z?O �3J :m 30C j10 3ll 33C �!J �5C 3&j 371j 
- '}GT .G ,.;lG .G 7G .G T ��TrT . GGI_-·GCGTG -� _" '_G � CT" fG":JTT':" (jf]t-,- �T('TGC I�J ( .. .-. GC 1",(::3T G'TTCG�S 'Tj.',�,S3':'GT j}�( ,�� GC JG-'G GTC"'!'� {11:. ,.._� .G:'·':cc�·� 'I 
,1\, )( r nI'l I. " 'I ',' .'V ! \'� J tiJ',' :,;\' : in II) 'i/" l IV ; ('d i n�l ,\,1 , j\d 1;, ,', ,�I '  nJIA C, :N I:) V'h' '.'.1\ " /r',�M' '1 'l'lt "- " "f!' 'A, 
:f:J 38tJ 4I)J 4.:.0 41 4l.l .;4D 450 4:1l 47.: 4Sj .,l) 
G , '1\;Tf T.,..,CC J..tJ __ �"-'f.. !.C GC f T�TG(' C��\.. �CGT j·d:G.1G Gc\i.G7� · .,."GGT G�G I',CG;·(�TGCCCG\}TGC�C'3 ��=J'rT • .  GG ''''' G(·GTr �.G7 '''G'' .\ :G m'(J GCGfT G  TI] . ".; 
5:.� 5:') 520 ': ':; )J1 (I� t};: JG�CG': �L·�CT I'T 
�)( 











::D 5�?:J tiOO 
TG .",TtJG-:.; Gf t' f""O -. ,""" - ... J l ''; J ;,1' .!J G Tf'7!" 
t,:C' 
"'f' 'G � 
i:X 
:;[ c:,  
-, �, .i\ /'''' ;'r '}:,( \. ' . � � �_" "",: ' •. "''':� � .. J, ./ .' '{\ .. '\ __ � , . ('-./J, _ 
� � 
..;;. � 
... ... . 
II � ::: 
II t;) � I 
'"'" 
..... II 
' - '  , ,  � 
' _ J  r-,-.. .- > 
�-. � > 
c -, r: r 
.,,--, -=--� 




T '  t: !  
t. 
.-:. , · , 1 t • 
, - -
J : 
� · - • 
t '  
f"" 








�r-_ ___ · 
� I 
f ___ ' 
C_ "' 
<:- • 









< -' � Cl ::-.......::�, r:. L 
C"
� 





F ig. 1 1 : Sequenc ing chromatogram of the 23S rRNA gene i so lated 
form H. pylori Hpuae-l l  
- 1 1 3 -
� 
:J J. !l 4D 00 .c" 1 1  ID- I X-\'JG ... · �G t 'I� tT r{� 'J ,:;CCTG �GG G '�IJ ; LG G�J\J1 
�1. 
31)-; '.G IJ'� TC J .J  _ �.JI ...J � ,-. .  '''' ... 1 \2 ,. __ J ... ·"\ 04, ... .1"1 ... "" ,  J IJ J ,J � !: J �i � I ' t , ;1 j, ! ' l' 
.of.) 
TTS ,',�,' 
� , � , ( . I " 4\ 1 1 1,: ! \ : \ I l' V l l lJ/ij J I I . ' . � Il� , 1 \ JI: 
Fl 
"I" GG ' 
I' I 
1(0 






�r: � J , 
��o 
G -I;�r.Gf G 
B m � m � m � � 
GG: ,G ;'G G .TI} IGT TrlT".\GG(G�G"rJ ·� G · .:Tj�T,jGI' . GG 'fT':TG�, "T;:;-: I'C'iT ' GT�j"�'�G 
;:,] ::0 










30( '00 4(IJ 410 4:0 -3J .:.10 4:0 :ff �'it, 4:9:: 4.,. '} C TG'T1'T l-C,: 
"i]C 
TIC t:CC G -'J 
s· 
G C '\C'T rG CC�"CT :::Gr J] , � G '\G�"�" G ;TG:'G rCG:"T-:; CCGG"" :; C'1'C , 'l?GT '1' ,J G G , T-ZGT: \ G,;"�G 2. :;, ; . G '�G-;: r::; 
:�o 520 
GGG.'G(? f:�"!,� t LT I � 




T Tn� �r I:;: "GG'� T 
511 
�c .... :�I'" "" G 
:.3G 





.... .... . 






� 3-:: .- c->  





< . ,  , , 
'"-=. ' 
I�'" 




r- . r:.. 








r . ,  C �  
C ':">  
<1;:- ' ''' C·� C'> 
'-':' 
r 





< -' � 
r .., 
� t 




Fig .  1 2 : Sequenc ing chromatogram of the 23S rRNA gene 
isolated form H pylori Hpuae- 1 2  
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Fig .  1 3 : Sequenc ing chromatogram of the 23S rRNA gene isolated 
form H pylori Hpuae- 1 3  
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F ig. 1 4 : Sequenc ing chromatogram of the 23S rRNA gene i solated 
form H. pylori Hpuae- 1 4  
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Fig .  1 5 : equenc ing chromatogram of the 23S rRNA gene i solated 
form H. pylori Hpuae - 1 5  
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Fig .  1 6 : Sequenc ing chromatogram of the 23S rRNA gene i solated form 
H. pylori Hpuae- 1 6  
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F ig. 1 7 : Sequenc ing chromatogram of the 23S rRNA gene isolated 
fonn H. pylori Hpuae- 1 7  
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Fig.  1 9 : Sequenc ing chromatogram of the 23S rRNA gene isolated fonn 
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Fig .  20:  Sequenc ing chromatogram of the 23S rRNA gene i solated 
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